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ABSTRACT OF THE DISSERTATION
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and Selected Blood, Immune and Endocrine Indices in Adult Males.
by
Janet T. Peterson
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Loma Linda University, Loma Linda, California, 2002
Helen Hopp Marshak, Chairman
Over the past few decades it has become apparent that increased body weight,
specifically body fat, coupled with a sedentary lifestyle is associated with an increased
risk for chronic disorders such as cardiovascular disease and diabetes. Researchers are
now re-directing their focus on determining the cause of these relationships from an
epidemiological view to a more biological or physiological standpoint. The purpose of
this cross sectional study was to examine associations among obesity, physical activity
and select immune, endocrine and metabolic parameters identified as risk factors for
several chronic conditions. Ninety-one healthy males between the ages of 19 and 45
volunteered for this study. Anthropometric measures included height, weight, waist and
hip circumference, and percentage body fat, assessed by seven site skin-folds. Physical
activity data were collected on a self report questionnaire and was compared to the levels
suggested by the US Surgeon General. The endocrine, metabolic and immune parameters
measured were: lipid profiles, fasting blood glucose, cortisol, white blood cell count and
differentials, and lymphocyte proliferation. Percentage body fat was significantly related
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to a deterioration in the lipid profile as represented by an increase in both very low
density lipoproteins (r = 0.405, p<0.0008) and a decrease in the ratio of high density
cholesterol to total cholesterol (r = 0.469, p<0.0008). White blood cell count was more
strongly related to fat mass (r = 0.35, p<0.005) and percentage body fat (r = 0.35,
p<0.005) than BMI (r = 0.25, p<0.05) In addition, those who reported participating in
physical activity at or above the level suggested by the surgeon general had smaller waist
to hip ratios, lower percentage body fat, fat mass and more favorable lipid profiles
(p<0.05). This study demonstrated the necessity to further evaluate the accuracy of using
BMI as an indicator of obesity or chronic health risk in an adult male population. Future
investigations concerning obesity and morbidity and mortality should include
measurements of body composition and/or body fat distribution. Additionally, the results
of this study are in agreement with the latest US Surgeon General recommendations of
the positive health benefits of regular participation in physical activity. However, further
investigation is necessary to determine the optimal level of physical activity. Based on
the results of this study, medical professionals, preventive care specialist and allied health
professionals are encouraged to obtain measurements of body composition in addition to
using BMI when assessing chronic disease risk in their patients.
iv
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A. Statement of the Problem
The United States and other developed countries have come to accept the
relationship that a higher body weight is associated with greater health risk. The
prevalence of overweight or obesity (defined as a body mass index greater than or equal
to 25 and greater than or equal to 30, respectively) in the United States is on the rise
(Jakicic, Clark, Coleman, Donnelly, Foreyt, Melanson, et ah, 2001). Presently, there are 
an estimated 55-60% of adults with a BMI > 25 kg.m , and approximately 22% with a
BMI > 30 kg.m2 (Jakicic, et al., 2001). Obesity is also associated with a decrease in
quality of life as well as increased morbidity and mortality (Brochu, Poehlman & Ades,
2000). For example, the incidence of infectious illness in obese individuals is higher
when compared to lean controls (Chandra, 1981). Some of the many associations
between body weight and health risk include increased incidence of hyperlipidemia.
diabetes mellitus, atherosclerosis, infectious illness, heart disease, cancer and
hypertension (Burton, & Foster, 1985; Chandra & Kutty, 1980; Ferraro & Yu, 1995;
Jakicic, et al., 2001; Nieman, Henson, Nehlsen-Cannarella, Ekkens, Utter, Butterworth,
& Fagoaga, 1999; Palmbald, Hallberg & Rossner, 1977; Scanga, Verde, Paolone,
Andersen & Wadden, 1998; Segal, Dunaif, Gutin, Albu, Nyman, & Pi-Sunyer, 1987;
Tanaka, Inoue, Isoda, Waseda, Ishihara, Ymakawa, et al.,1995). Furthermore, an
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estimated 70 to 100 billion dollars are being spent on obesity related treatments each year
(Brochu, et ah, 2000; Jakicic, et al., 2001).
In addition to obesity, a major contributor the increased risk of mortality and
morbidity is a decrease in physical activity. Approximately half of young Americans
(ages 12-21 years) and nearly 70% of US adults do not participate in regular physical
activity (United States Department of Health and Human Services, 1996). Physical
inactivity increases the risk for many chronic disorders and may be considered an
independent risk factor for several chronic health conditions (Chakravarthy, Joyner &
Booth, 2002). Ultimately, the incidence of chronic conditions is most likely related to
synergistic and complex interactions between multiple risk factors, such as obesity and
physical inactivity.
B. Purpose of the Study
The purpose of this study was to examine the relationship among selected
anthropometric measures (body fat percent, body mass index, waist circumference
measurements and waist-to-hip ratio) and several immune function parameters including:
total leukocytes, neutrophils, monocytes, lymphocytes, basophils, eosinophils and
mitogen induced lymphocyte proliferation. Further, this study examined the relationship
among the anthropometric measures and several metabolic parameters including: total
serum cholesterol (TSC), low density lipoprotein cholesterol (LDL), high density
lipoprotein cholesterol (HDL), very low density lipoprotein (VLDL), triglycerides (TG),
fasting blood glucose (FBG) and serum cortisol. Finally, the effect of self reported
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physical activity on the anthropometric measures and metabolic parameters was
examined.
C. Research Questions
1. Is there a linear association between selected anthropometric measures (weight,
waist circumference, waist to hip ratio, body mass index, percentage body fat).
resting immune function and serum levels of glucose, triglycerides, cholesterol
(total, low density lipoprotein, very low density lipoprotein and high density
lipoprotein), hemoglobin, hematocrit, cortisol and fasting blood glucose?
2. Which anthropometric measure (weight, waist circumference, waist to hip ratio,
body mass index, percentage body fat) have the strongest correlation with
selected markers of immune, endocrine and metabolic function?
3. Do males who participate in physical activity, of moderate to vigorous intensity,
at least 30 minutes per day on most days of the week, have more favorable
anthropometric or metabolic indicators (cortisol, lipid profile and fasting blood




REVIEW OF THE LITERATURE
A. Introduction
Few studies have attempted to delineate the etiology of the increased health risks
related to either the low or the high end of the weight continuum. Burton and Foster
(1985) indicate that a weight of 20% or more above desirable body weight is associated
with a sufficient risk to health to justify clinical intervention (Burton & Foster, 1985).
However, the level of "fatness" at which ones health becomes impaired has not been
determined. Research has suggested that obesity, as measured by an increase in body fat,
adversely affects health and longevity (Lohman, 1992). Lohman (1992) defines obesity
as an excess of body-fat which may result in health impairments. Baik et al. (2000)
concluded that excessive body fat contributes to mortality at all ages. In addition to the
overall amount of fat, other researchers have looked at fat distribution, determined by
waist circumference, as an indicator of increased risk for cardiovascular disease and
overall mortality (Folsom, Kushi, Anderson, Mink, Olson, Hong, et al., 2000). It may be
possible that percentage fat, body mass index and increased waist girth are related to an
attenuation of baseline immune and metabolic function, which in turn may increase risk
for morbidity and mortality. This review of the literature examines some of the possible
relationships between anthropometric measures and several immune and metabolic
indices in an attempt to further delineate the cause of increased morbidity and mortality




There is a growing body of scientific literature indicating the harmful
medical and psychological consequences of being overweight with negative effects on
quality of life and longevity (Abernathy & Black, 1994; Allison, Faith, Heo & Kotler,
1997; Burton & Foster, 1985; Chandra, 1981). The relationship between high body
weight and incidence of chronic health conditions has been described by many authors
(Baik, Ascherio, Rimm, Giovannucci, Spiegelman, Stampfer, & Willett, 2000; Blair &
Brodney, 1999; Ferraro & Booth, 1999; Ferraro & Yu, 1995; Lew & Garfinkel, 1979;
Wei, Kampert, Barlow, Nichaman, Gibbons, Paffenbarger & Blair, 1999). In 1985, the
National Institutes of Health Consensus Development Conference concluded that
obesity, defined as an excessive storage of energy in the form of fat, has adverse effects
on health and longevity (Burton & Foster, 1985). Severe obesity has been associated
with increased mortality (Anker & Coats, 1999; Manson, Willett & Stampfer, 1995;
Singh, Lindsted & Fraser, 1999). Specifically, a weight of 20% or more above desirable
body weight is associated with a sufficient risk to health to justify clinical intervention
(Burton & Foster, 1985) and a weight gain of >10 kg is associated with increased
mortality in both men and women (Anker & Coats, 1999).
Lew and Garfinkel (1979) examined the variations in mortality by weight among
750,000 men and women, a sample drawn from the general population. The sample was
selected from the long-term prospective study conducted by the American Cancer
Society over the period from 1959-1972. The lowest mortality rate was found in the
average weight groups and among those in the 10-20% below average group. Groups
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that were equal to or greater than 30% heavier than average, for both men and women,
were associated with higher mortality with nearly 90% higher mortality among those
40% or more above average weight when compared to those of average weight
(mortality ratio = 1.87 as compared to the average group).
The data in regard to underweight and morbidity and mortality are inconsistent at
best. For example, patients with anorexia nervosa remain remarkably free of infections
even at very low body weights (Fink, Eckert, Mitchell, Crosby & Pomeroy, 1996).
Manson et al. (1995) examined the association between BMI and overall mortality in a
cohort of the Nurses’ Health Study and found no evidence of increased mortality in the
leanest group (BMI <19) of non-smoking women. However, in the Lew and Garfinkle
(1979) study summarized above, mortality for underweight men and women (20% or
more below average weight) was 25% and 20% higher than average weight,
respectively. In a review of the literature, Gaesser (1999) concluded that much of the
epidemiological data indicate that thinness (BMI < 20), in both men and women, is
related to relatively high mortality rates. Additionally, starvation leads to death at
approximately 66% of initial body weight (Anker & Coats, 1999; Cahill, 1970). Thus,
more definitive research is needed to delineate the health risks associated with thinness.
2. Anthropometric Measures
a. Body Mass Index (BMP. Most of the studies examining body weight
and mortality done to date are large-scale epidemiological studies which use the body
mass index (BMI) or quetelet index, defined as weight in kilograms divided by the square
of the height in meters (kg/m2) to estimate body composition (Abernathy & Black, 1994;
Burton & Foster, 1985; Ferraro & Yu, 1995; Michels, Greenland & Rosner, 1998;
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Palmbald, Hallberg & Rossner, 1977). BMI has been shown to have a direct relationship
to morbidity and mortality in studies of large populations (Burton & Foster, 1985;
Manson, Willett & Stampfer, 1995; Singh, Lindsted & Fraser, 1999; Wei, Kampert,
Barlow, Nichaman, Gibbons, Paffenbarger, et ah, 1999). Wei et al., (1999) examined
prospective observational data from 25,714 subjects in the Aerobics Center Longitudinal
Study in an effort to quantify the influence of cardiorespiratory fitness on all-cause
mortality in normal-weight, over-weight and obese males as defined by BMI. In addition
to low cardiorespiratory fitness contributing to mortality risk, these investigators reported 
that obese men (BMI >30 kg/m ) had 2.6 times higher risk for cardiovascular disease
(CVD) and a 1.9 times higher risk for all-cause mortality compared with normal weight
men (BMI, 18.5 - 24.9 kg/m2).
BMI is a mathematical representation of height and weight and does not take into
consideration body composition such as body fat percentage or lean body mass
(McArdle, Katch & Katch, 1996). In fact, BMI can be misleading in those individuals
who have a high percentage of lean body mass or are short in stature (Yanovski, 2000).
BMI is correlated with percentage body fat as assessed by hydrostatic weighing with the
correlations (r) ranging from 0.70 - 0.90 (Keys, Fidanza, Karvonen, Kimura & Taylor,
1972; Willett, Dietz & Colditz, 1999). However, BMI alone may not adequately assess
the relation of certain health outcomes and body composition in the general population
(Michels, Greenland, & Rosner, 1998; Segal, Dunaif, Gutin, Albu, Nyman, & Pi-Sunyer,
1987). To account for the possible misclassifications related to BMI, some authors
indicate that body composition or percentage body fat rather than body mass index is a
major determinant of health outcomes (Allison, et al., 1997; Michels, Greenland &
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Rosner, 1998; Segal, et al., 1987) and should be included when examining risk factors
related to body weight. Yanovski et ah, (2000) suggests that investigations to evaluate
the health risks in obese or overweight individuals should include BMI as well as a
measure of body fat distribution as the latter is an independent predictor of health risks.
Segal et al. (1987) examined several cardiovascular risk factors (blood pressure, 
lipid profile, and plasma insulin) in overweight and obese, overweight and lean, and 
normal weight and lean men. Overweight was determined by BMI (>25 kg/m2) for 
which there was no statistical difference between the overweight/obese and 
overweight/lean group (30 ± 1 kg/m ). Obesity was determined by percentage fat (>
25%) utilizing hydrostatic weighing for which the percentage body fat did not differ
statistically between the overweight/lean and normal weight/lean groups (10 ± 1 and 12
± 1, respectively). Body fat percentage was positively correlated with systolic blood
pressure (r=0.60, p<0.01), low density lipoprotein (LDL) cholesterol (r=0.56, p<0.01),
total serum (TC) cholesterol (r=0.53, p<0.01) and negatively with high density
lipoprotein HDL/TC ratio (r= -0.63, p<0.01). Total body weight was not significantly
correlated with any of these parameters (BMI was not used for comparison). BMI is
calculated using total body weight and does not take into consideration body
composition. Although BMI plays an important role in many epidemiological
investigations, using it independently may not be sufficient when discussing health
outcomes.
b. Circumferences. Another popular method often used to estimate body
fat content or fat distribution is the waist to hip ratio (WHR), or simply the waist
measurement, each of which have been associated with increased risk for diseases such
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as diabetes, hypertension, hypercholesterolemia and coronary heart disease (Abernathy
& Black, 1994; Rimm, Stampfer & Giovannucci, 1995; Segal, et ah, 1987; Willett, Dietz
& Colditz, 1999). Circumferences are used to indicate the distribution of the fat in either
a truncal or central location. Centrally located fat has been associated with increased
health risk for a variety of health outcomes (Chan, Rimm, Colditz, Stampfer & Willett,
1994; Rimm, et al., 1995).
Specifically, the higher waist to hip ratios have been associated with increased
health risks independent of total body weight (Chan, et al., 1994; Rimm, et al., 1995).
Recently, at least two investigators have suggested that the waist measurement alone is
independently related to increased health risks, such as cardiovascular disease or
diabetes, regardless of total body weight or hip measurement (Chan, et al., 1994;
Molarius & Seidell, 1998). In addition, body circumferences have been correlated with
percentage body fat and are practical methods to use in a clinical setting.
3. Summary
Increased body weight, and more specifically increased body fat, has been
associated with higher morbidity and mortality. In addition, thinness has been associated
with increased morbidity and mortality, although the evidence is mixed. The ability to
accurately represent body weight or body fat has been debated through out the literature.
BMI has replaced the standard height to weight charts in most of the recent
epidemiological studies. However, BMI may not accurately represent increased disease
risk because it does not take into account body composition or body fat location.
Therefore, as indicated in some of the current literature, other measures of obesity, such
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as waist circumference, waist to hip ratio and body fat percentage are suggested to be
more accurate for evaluation of chronic disease risk.
C. Immune Function
1. Overview
The immune system is crucial to human survival (Paraham, 2000). The
immune system protects us from harmful foreign matter and microorganisms (antigens)
that may cause disease. The defense processes involved in immune function are very
complex; a comprehensive review of the immune system can be found elsewhere
(Herbert & Cohen, 1993; O'Leary, 1990; Paraham, 2000; Roitt, Brostoff & Male, 1998).
Researchers suggest that obesity is associated with a decrease in immune function
(Nieman, Henson, Nehlsen-Cannarella, Ekkens, Utter, Butterworth, et al., 1999).
Immuno-suppression has been linked with an increased risk for infectious illness
(Glaser, Rice, Sheridan, Fertel, Stout, Speicher, et al., 1987) and certain immune
parameters such as high total leukocyte count can be considered as an independent risk
factor for cardiovascular disease (Grimm, Neaton, & Ludwig, 1985; Nieman, et al..
1999).
2. Immune System Markers
a. Introduction. Several specific markers for identifying immune function
have been suggested throughout the literature (Glaser, Rice, Sheridan, Fertel, Stout,
Speicher, et al., 1987; Grimm, Neaton & Ludwig, 1985; Hoffman-Goetz & Pederson,
1994; Nieman, Henson, Nehlsen-Cannarella, Ekkens, Utter, Butterworth, et al., 1999).
The most common laboratory evaluations used to assess immune function consistently
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are total white cell count, natural killer (NK) cell activity, lymphocyte subsets and
mitogen induced lymphocyte proliferation (Berk, Tan, Nieman & Eby, 1987; Boeck,
Chen, & Cunningham-Rundles, 1993; Deitch, 1993; Dinarello & Wolff, 1993;
Herberman & Ortaldo, 1981; Herbert & Cohen, 1993; Kang, Coe, McCarthy & Ershler,
1997;. O'Leary, 1990; Pedersen & Ullum, 1994).
b. Total Leukocyte Count and Leukocyte Subsets. Leukocytes or white
blood cells (WBC) are involved in virtually all aspects of immune function such as
production of antibodies, killing of bacterially and virally infected cells, phagocytosis and
killing of microorganisms (Mackinnon, 1999; Paraham, 2000). On average there are
7,000-10,000 leukocytes per deciliter of whole blood (Rhoades & Pflanzer, 1996). The
polymorphogranulocytes account for 60-70% of all circulating leukocytes, the
lymphocytes (including T, B and NK cells) compromise 20-25% of circulating
leukocytes and monocytes account for approximately 15% of circulating leukocytes
(Mackinnon, 2000). Each type of leukocyte is responsible for a particular function with­
in the complex immune response. However, the overall immune response is a coordinated
effort that relies on the interaction of all the WBCs acting in concert.
The clinical effect of increased leukocyte numbers depends greatly on the
etiology. For example the clinical and biological significance associated with the change
in leukocyte numbers linked with chronic exercise are unknown at present (Mackinnon,
2000). However, high WBC counts have been considered as an independent risk factor
for coronary heart disease and have been associated with alterations in coagulation
factors, glucose metabolism and triglyceride metabolism (Grimm, Neaton, & Ludwig,
1985; Nieman, et al., 1999; Nieman, Nehlsen-Cannarella, Henson, Koch, Butterworth,
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Fagoaga & Utter, 1998). An increase in specific subsets of WBCs may also be involved
in the atherosclerotic process. Other studies have indicated that there is an increase in
oxygen free radicals with an increased neutrophil count and increases in other oxidation
metabolites with an increase polymorphonuclear leukocyte count (Grimm, Neaton &
Ludwig, 1985).
c. Lymphocyte Subsets. There are several different types of lymphocytes,
including NK cells, T-Cells and B-Cells. Quantifying the number of circulating cells is
important because a minimum number is required for the immune system to respond
effectively to an antigenic challenge (Herbert & Cohen, 1993). However, the number of
different cell types may not correlate with functional capacity of the immune system
(Herbert & Cohen, 1993). In addition, the actual health consequences of small changes
in absolute or relative numbers of lymphocyte subsets in peripheral blood have not been
determined. Nonetheless, many studies have included these relatively easy assays
(Herbert, & Cohen, 1993).
d. Lymphocyte Proliferation. Lymphocytes become activated to enter the
cell cycle and proliferate in response to antigen or other challenge (Paraham, 2000). The
use of an antigen challenge, such as pokeweed or Concavalin-A to stimulate the
proliferative response is important in assessing functional capacity. The absolute
numbers of circulating lymphocytes do not necessarily correlate with functional capacity
(Herbert & Cohen, 1993). Although the research has not, as of yet, determined an exact
cause and effect between lymphocyte function and morbidity and mortality, it is assumed
that the more proliferation that occurs, the more effectively the cells are functioning
(Herbert & Cohen, 1993), thus suggesting an overall immunoprotective effect.
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D. Immune Function and Body Composition
1. Obesity
In addition to increased health risks, obesity has also been associated with
impaired immunocompetence in both humans and animals. (Boeck, Chen &
Cunningham-Rundles, 1993; Chandra, 1981; Nieman, Henson, Nehlsen-Cannarella,
Ekkens, Utter, Butterworth, et ah, 1999; Palmbald, Hallberg & Rossner, 1977; Tanaka,
Inoue, Isoda, Waseda, Ishihara, Ymakawa, et ah, 1995). Few studies have been done that
examine the relationship between body composition and immune function as a possible
mechanism of action for the increase in morbidity and mortality associated with obesity.
Neiman et al. (1999) examined the resting NK cell activity, lymphocyte subsets.
lymphocyte proliferation and leukocyte phagocytosis/oxidative burst of 116 obese (BMI
> 25) and 41 non-obese (BMI < 25) subjects. Blood counts (total leukocytes, neutrophils,
lymphocytes and monocytes), total lymphocytes, T-helper and B-cells were significantly
elevated in the obese subjects (p<0.05). Both BMI and percentage body fat were
significantly correlated (r=0.44, p<0.001 and r=0.38, p<0.001, respectively) with total
leukocyte count. Obese subjects had a significantly lower percentage of mitogen-induced
lymphocyte proliferation (p <0.001) than the non obese subjects. This and other studies
suggest that obesity is related to higher blood levels of total leukocytes, neutrophils and
monocytes (Grimm, et al., 1985; Nieman, et al., 1998) and lower mitogen-induced
proliferative response (Tanaka, Inoue, Isoda, Waseda, Ishihara, Ymakawa, et al., 1995).
Scanga et al.(1998) compared NK cell activity, leukocyte and lymphocyte numbers
in 22 obese women who were randomly assigned to a diet alone group (D) or a diet plus
exercise (DE) group. The diet consisted of approximately 900-925 kcal/day with 34% of
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the daily caloric intake from protein, 47% from carbohydrate and 19% from fat. Although
this study had many threats to validity (low power, loss of subjects, subject history,
immunological techniques) and the investigators based their conclusions on clinically
significant results rather than statistically significant outcomes, some interesting results
were found. After the eight-week intervention, only the D group showed a significant drop
in NK cell activity (1.22±1.60, LU-50%). There was no difference between the D and DE
groups related to BMI decrease over the eight-week intervention, although both groups
decreased weight significantly. Body composition changes were not assessed, however
the DE group had a significant strength increase (33%, p<0.05) as measured by amount of
weight lifted during the training sessions. Strength was not evaluated in the D group for
comparison. It is possible that increasing strength may be associated with an increase in
muscle mass or fat free mass and a decrease in fat mass which may have positively
affected the immune parameters measured.
2. Underweight and Normal Weight
Impaired immuno-competence has also been associated with underweight
(BMI < 18.5) individuals, however, most of the research has been done in severely
malnourished or diseased individuals rather than a relatively healthy population (Anker &
Coats, 1999; Chandra, 1981; Fink, Eckert, Mitchell, Crosby & Pomeroy, 1996). Little
research is available on the immune function of normal weight individuals except for use
as a control or comparison groups in various studies (Berk, Tan, Nieman & Eby, 1987).
3. Summary
Body weight has been associated with alterations in immune function in
both human and animal models. Specifically, studies have examined the immune
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response in overweight individuals and indicate that obesity is associated with
immunocompetence. Additionally, there have been few studies done to date that assess
the immune response to body fat levels independent of weight. Most of the immune
function data related to body weight have used BMI to indicate overweight or obesity.
There are few studies that examine immune function in normal weight or underweight
individuals. Researchers suggest that future investigations examine several
anthropometric measures to better understand the relationship of body fat and immune
function.
E. Metabolic Indices and Body Composition
1. Hypothalamic-Pituitary-Adrenal (HPA) Axis
The HPA axis involves a complex interaction between the hypothalamus,
the pituitary gland and the adrenal glands. The hypothalamus produces neurotransmitters
that regulate the release of corticotropin releasing factor (CRT) which in turn induces the
pituitary to secrete adrenocorticotropin hormone (ACTH). The ACTH stimulates the
adrenal cortex to produce glucocorticoids such as cortisol. The cortisol levels are
maintained by a negative feedback loop, when the levels get to high, the cascade is down
regulated (Solomon, 1996) (Figure 1).
Obese animals have demonstrated hyperactivity of the HPA axis or glucocoritcoid
action in the central nervous system (Vettor, Macor, Novo, Gottardo, Zovato, Simoncini,
Federspil & Armanini, 1998). Also, hyperactivity of the HPA axis with increased ACTH
response to stress has been found in obese humans (Vettor, Macor, Novo, Gottardo,
Zovato, Simoncini, et al., 1998). Increased cortisol levels have been shown to impact the
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immune system; the T-cells are particularly acutely sensitive to the glucocorticoids as
shown by a decrease in activity in the presence of high cortisol (Solomon, 1996).
Figure 1. The Hypothalamic-Pituitary-Adrenal (HPA) Axis.
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Adapted from Solomon, 1996.
For example, increased cortisol has an immunosuppressive effect on T-
lymphocytes as indicated by reduced lymphocyte proliferation and altered cytokine
response (Falaschi, Martocchia, Proietti, & D'Urso, 1999). Hyperactivity of the HPA axis
and high glucocorticoid levels are thought to induce a significant immune suppression
(Falaschi, Martocchia, Proietti, & D'Urso, 1999). Therefore, if obesity is related to
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increased activity of the HPA axis, it is possible that an increase in percentage body fat or
fat mass may play a role in immune-suppression possibly mediated through an increased
production of stress hormones such as cortisol (Figure 2).
Figure 2. Possible Mechanism of Action for an Association Between Increased Body Fat
and Impaired Immune Function.










2. Selected Metabolic Markers Related to Body Composition
Obesity, physical inactivity and insulin resistance have been recognized as
independent predisposing risk factors for many of the chronic diseases such as
cardiovascular disease (CVD), type 2 diabetes and syndrome X in epidemiological
investigations (Grundy, 1999; Henry, 2001). Increased risk for chronic disease is also
associated with altered serum lipids including increased total serum cholesterol (TSC),
low density lipoproteins (LDL), very low density lipoproteins (VLDL) and serum
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triglycerides, and decreased high density lipoproteins as well as increased fasting plasma
glucose (Grundy, 1999). Hyperglycemia is recognized as an independent risk factor for
cardiovascular disease (Henry, 2001). Grundy (1999) proposes that the negative effects
of physical inactivity and obesity on insulin resistance may, in turn, be related to an
increase in the causal factors related to the incidence of CVD.
It has been suggested that increased cortisol levels are associated with increased
insulin resistance, changes in lipid metabolism and incidence of obesity (Fraser, Ingram,
Anderson, Morrison, Davies & Connel, 1999). In fact, some investigators suggest that
cortisol may be a contributor to obesity in many individuals. In males, there is a clear
relationship between abdominal fat deposition and increased cortisol (Fraser, Ingram,
Anderson, Morrison, Davies & Connel, 1999). Fraser et al (1999) examined the
relationship between urinary cortisol excretion and several risk factors in 439 normal
subjects. Cortisol excretion correlated significantly with BMI (r = 0.34, p<0.001), waist
measurements (r= 0.29, p<0.01), hip measurements (r = 0.31, p<0.01) and HDL
cholesterol (r= -0.27, p<0.01). Although the underlying physiological action of
hypercortisol secretion is not well understood, these results are in agreement with the
proposed relationship between cortisol levels and causal/predisposing risk factors for
chronic disease.
F. Conclusions
Research studies suggest that body composition (fat mass or lean body mass)
more than BMI is a primary determinant of health (Allison, et al., 1997; Segal, et al.,
1987). BMI, as suggested by many researchers, does not accurately represent fat mass,
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and a higher correlation between health risks and obesity may be found if body fat
percentages were evaluated (Abernathy & Black, 1994; Burton, & Foster, 1985). Very
few studies have assessed the relationship between immune function and body
composition and/or waist circumference. The mechanism underlying the
immunosuppressive effects of body fat and body weight are not clear, but may be related
to alterations of the HPA axis (Scanga, Verde, Paolone, Andersen & Wadden, 1998).
Tanaka et al. (1993) indicates that the optimum BMI range for immunity remains
unresolved. BMI may not be the best predictor for immune function, whereas body
composition, specifically percent body fat mass or fat distribution may be more accurate
indicators. Specific research is needed to determine the relationship of percent fat and/or
waist circumference to immuno-competence and metabolic disturbances in an effort to
delineate some of the mechanisms of action related to increased morbidity and increased





This was a cross-sectional, observational study that examined possible
relationships among anthropometric measures and various immune, endocrine and
metabolic measures.
B. Subjects
Ninety-one male subjects were recruited through advertisements according to the
following inclusion criteria: are between the ages of 19 and 45, inclusive; are non-
smokers (must have quit at least six months prior to the participating in the study); do not
have a diagnosed chronic illness including (but not limited to): cardiovascular disease,
diabetes, autoimmune diseases, respiratory disorders, cancer, etc; have not had an
infection such as a cold, flu or other type of infection with in the last month; are not
experiencing chronic pain; do not have serious sleep disturbances; do not have serious
allergies and have not had an allergic reaction with in the last month; do not have salient
emotional or mood problems; have not had a recent bone fracture (with in the last six
months); have not undergone surgery with-in the last three months; are willing to comply
with study procedures; and are able to complete the protocol as designed.
The Institutional Review Boards (IRB) at Loma Linda University and California
State University, Fullerton (Appendices A through D), approved the study protocol, prior
to initiation of the study. Informed consent was obtained from all subjects. At the time of
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IRB submission, Dr. Helen Hopp Marshak was not involved with this study. Dr. Hopp
Marshak joined my dissertation committee during the spring of 2002.
C. Procedures
All subjects reported to the laboratory between the hours of six and nine in the
morning in a 12-hour fasted state. The data collection procedures were then done as
follows:
1. The study procedures were explained to the subject by the principal
investigator at which time they read and signed the informed consent.
2. The subject completed the self-report physical activity questionnaire
3. The subject was then escorted to the phlebotomy area to have his blood
sample drawn. All blood samples were taken from a vein in the anticubital
fossa with the subject in a seated position. Each subject had approximately 25
milliliters (ml) of blood taken and distributed into three vacutainers. After the
venous sample was obtained, the subject underwent a finger stick with a lancet
to obtain a drop of blood for the fasting blood glucose measurement. A
medical doctor preformed all of the blood sampling.
4. The subject was then escorted to the anthropometric measurement area.
Height and weight were taken initially, afterwhich the waist and hip
circumferences were measured. Finally, the seven site skin folds were
performed and recorded.
5. The subject was then escorted back to the screening area and given orange
juice prior to leaving the building.
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D. Body Composition and Circumference Measures
1. Body Circumference Measures
The methodology for obtaining the waist and hip measurements is as
described in the ACSM guidelines (ACSM, 1995; 2000). Subjects had their waist and hip
circumference measured to the nearest quarter inch. The measurements were taken with
the subject standing in an erect position and their abdomen relaxed. For the waist
measurement, a horizontal measure was obtained at the narrowest circumference between
the xiphoid process and umbilicus. The hip measurement was taken at the widest
circumference above the level of the gluteal folds. Each measurement was confirmed
twice to the nearest quarter inch. The waist-to-hip ratio was then calculated from the
average waist and hip measurements.
2. Body Composition
Body composition was assessed using the 7-site skin fold method. The
seven subcutaneous skin fold sites measured in this study were performed as described by
the ACSM Guidelines (ACSM, 2000). The anatomical locations measured were:
abdominal, chest/pectoral, midaxillary, subscapular, suprailium, thigh and triceps. All
skin fold measurements were performed twice, by the same investigator, for accuracy and
the average of the two measures was than calculated. Measures that were not with-in two
millimeters of each other were repeated. All skinfold measurements were performed
using a Lange Skinfold Caliper (Cambridge Scientific Industries, Inc, Cambridge, MD).
Body density was determined by applying the 7-site regression formula as described in
the ACSM manual (ACSM, 2000). Percent body fat was then determined by the Siri
formula (Lohman, 1992).
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3. BMI Category and Percentage Fat Grouping
Subjects were categorized into groups based on percentage body fat and
BMI. The grouping for percentage body fat were lean, normal and overfat as follows:
Lean was defined as having a percent body fat less than or equal to 10; Normal was
defined as a body fat percentage greater than 10 and less than 20; and overfat was defined
as a percent body fat equal to or greater than 20 (Lohman, 1995). The grouping for BMI
were underweight, normal and overweight as follows: Underweight was defined as a
BMI less than 19, normal was defined as a BMI from 19 to less than 25 and overweight
was defined as a BMI greater than 25 (Jakicic, Clark, Coleman, Donnelly, Foreyt,
Melanson, et al., 2001).
E. Physical Activity
To assess the level of physical activity, a self-report questionnaire was developed
with the intention of collecting levels of physical activity and relating those levels to that
recommended by the US Surgeon General (Centers for Disease Control and Prevention,
1996). This instrument was administered after the subject had signed the informed
consent. The questionnaire was designed to assess planned physical activity (exercise)
and spontaneous physical activity. Each possible response was assigned a numerical
value, with zero indicating none or not applicable. All of the responses were then added
to obtain an overall score for planned and spontaneous physical activity. The total
physical activity score was determined by combining the planned and spontaneous
physical activity scores. The overall range for the total physical activity score was zero to
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34.5. The physical activity instrument used for this study was not tested for reliability or
validity.
1. Planned Physical Activity
Planned physical activity was determined by assessing the number of days
per week the subject exercised, how long each exercise session lasted, type of exercise
(weights, cardiovascular, or combination of both), and intensity. Intensity was assessed
using a Rating of Perceived Exertion (RPE) scale (Borg, 1974). A planned physical
activity score was assigned based on a scale from zero to 27. Using this methodology, an
individual who reported participating in moderate physical activity, 30 minutes a day for
most days of the week (at least four) as recommended by the US Surgeon General would
be assigned a minimum planned physical activity score of 15 (CDC, 1996).
2. Spontaneous Physical Activity
Spontaneous physical activity was determined by assessing the physical
activity required by the subject’s occupation, how often the subject takes the stairs as
compared to the elevator or escalator; how often they walk or ride on short trips; and how
physically active they are during their leisure time. A spontaneous physical activity score




1. Routine Complete Blood Counts (CBC)
Routine CBCs were performed by the Jerry L. Pettis Memorial Veterans
Affairs Medical Center, Department of Hematology, Pathological and Laboratory
Medicine Services on a AD VIA 120 (Bayer Corporation, Bayer Diagnostics Division,
Tarrytown, New York, USA). Variables measured included, red blood cell count (RBC),
hemoglobin (HGB), hematocrit (HCT), platelet numbers (PLT), mean plasma volume
(MPV), white blood cell count (WBC) and white blood cell differential (neutrophils.
lymphcytes, monocytes, eosinophils and basophils).
2. Triglycerides and Cholesterol
For each subject 10 ml of blood were collected into a heparinized
vacutainer which was then centrifuged at 1,500-1,800 rpm (Fisher Scientific Centrific,
model #225, Fisher Scientific, Tustin, CA, USA). Two milliliters of plasma were
removed and stored in one-ml sterile epitubes at -70°C. After the last subject had been
tested, the plasma samples were delivered, frozen, to the USC Lipid Laboratories (Los
Angeles, CA) for analysis of the TC, HDL and TG on a Cobas Mira Lipid analyzer
(Roche Diagnostic System). LDL and VLDL cholesterol were estimated by the
Friedewald equation (Friedewald, Levy & Fredrickson, 1972) after which, the TC to HDL
cholesterol ratio was determined.
3. Mitogen Induced Lymphocyte Proliferation Assay
The mitogen induced proliferation response of lymphocytes was
determined using whole blood culture with concanavalin A (Con A) and
phytohemagglutinin (PHA). The lymphocytes were isolated and re-suspended in RPMI
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1640 without 1-glutamine (Cellgro by Mediatech, inc, Fisher Scientific, Tustin, CA, 
USA) at 2.5 x 106 cells/ml. For each subject, 120jal of the re-suspended culture was
added to 1.37 ml of medium. This suspension was mixed and distributed in one row of a
96-well round bottom plate. Con A and PHA were added in quadruplicate to the
lymphocyte cultures at 1.5 qg/ml and 5 pg/ml respectively, four wells remained untreated
to serve as unstimulated controls. The plates were incubated at 37°C in a 5% CO2
humidified air incubator (Sanyo Electronic Biomedical, Fisher Scientific, Tustin, CA,
USA) for 72 hours. After the 72 hour incubation, 20 pi of tetrazolium salt (MTT) at a
concentration of 5 mg/ml was added to all wells and the plates were incubated for an
additional four hours. The plates were then centrifuged (Fisher Scientific Centrific, model
#225, Fisher Scientific, Tustin, CA, USA) and the cells washed with a Phosphate Buffer 
solution with 1-2% heat inactivated (56°C for one hour) fetal calf serum (Summit
Biotechnology, Fort Collins, CO, USA). After the last wash, 150pls of acidified
isopropanol was added to each well.
The optical density (OD) of each well was then measured with a microplate
spectrophotometer (Dynatech Laboratories Microplate Reader MRX, Thermo
Labsystems, Chantilly, VA, USA) equipped with a 570nm filter. Control samples were
quantified for each day of testing. The mean and standard error were determined for




For each subject, a 10 ml blood sample was collected in a serum separator
tube. The tube was then centrifuged at 3,000 rpm (Fisher Scientific Centrific, model
#225, Fisher Scientific, Tustin, CA, USA) for 10 minutes. The serum was removed and
stored at -70°C in sterile epitubes. Once all samples had been collected, the serum was
shipped, frozen, to Endocrine Technologies, Inc (Newark, CA) for determination of
cortisol levels using an Elyza Plate Reader (Biotech Instruments, model ELX 800). All
samples, including controls were analyzed simultaneously, at the end of the study.
G. Statistical Analysis
Data were entered and analyzed using SPSS 10.0 software package (SPSS, Inc.,
Chicago, IL, 2000). Analysis included standard descriptive statistics and frequencies.
Statistical significance was set at the p< 0.05 and values are expressed in mean ± SE
unless otherwise noted.
1. Obesity and Metabolic Parameters
Pearson correlation coefficients were used to test the linear relationship
between selected anthropometric parameters and all metabolic measures and between
selected anthropometric parameters and immune indices. Additionally the correlations
had the Bonferroni adjustment applied to minimize the possibility of a Type 1 error.
Independent t-test was used to compare the means of the exercising and non-exercising
groups for all measured variables. For selected metabolic variables, a z-score was
calculated using the correlation coefficients for BMI and Body fat. These z-scores were
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then tested for significance to determine if there was a difference between the
correlations.
2. Immune Function Parameters
Pearson correlation coefficients and multiple regression procedures were
used to test the linear relationship between anthropometric measures and immune
function. One-way ANOVA was used to compare the three categories (lean, normal and
overfat) based on percent fat for all measured variables. Independent t-test was used to
compare the normal and overweight categories of BMI and to compare the normal and
over fat category of percent fat for all measured variables.
3. Other Parameters
A One-way ANOVA was used to investigate the relationship between type
of physical activity (weights, cardiovascular, both or none) and cortisol level. In the case
that significance was found a LSD post-hoc analysis was done to further delineate the
significance of pair-wise relationships.
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ABSTRACT
Purpose: The aim of this study was to investigate relationships among several
anthropometric measures (weight, body mass index, body fat distribution and body fat
percentage) and selected parameters to assess immune function. Methods: Ninety-one
healthy males aged 19-45 were recruited for this study. Body mass index was determined 
using the Quetelet formula (kg/m ), waist and hip circumferences were measured, and
percent body fat was assessed using the 7-site skin fold method. Immune function was
assessed by white blood cell count, differential and lymphocyte proliferation. Results:
Twenty four percent of the subjects (n=21) were classified differently when comparing
BMI classification with classification based on percentage body fat. Percentage body fat
had a stronger positive relationship to white blood cell count than BMI (r=0.35, p<0.005
and r=0.25, P<0.05, respectively). None of the measured parameters were correlated with
lymphocyte proliferation. As determined by multiple regression, fat mass was an 
independent anthropometric predictor of white blood cell count (R =0.19, p=0.440
p<0.05). Conclusion: The relationship of fat mass and white blood cell count was
stronger than any of the other anthropometric measures.Elevated WBC has been linked
with increases in chronic diseases and mortalitiy. Thus, these results imply that fat mass
may be a better measure to determine disease risk. Future investigations concerning
obesity, morbidity and mortality should include measurements of body composition
and/or body fat distribution. Key words: BODY COMPOSITON, FAT
DISTRIBUTION, WHITE BLOOD CELLS, LYMPHOCYTE PROLIFERATION
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INTRODUCTION
Paragraph Number 1 The United States and other developed countries have come to
accept the relationship that a higher body weight is associated with greater health risk.
The prevalence of overweight or obesity (defined as a body mass index (BMI) greater 
than or equal to 25 and greater than or equal to 30, respectively) in the United States is on 
the rise (20). Presently, there are an estimated 55-60% of adults with a BMI > 25 kg.m2, 
and approximately 22% with a BMI >30 kg.m (20). Obesity is associated with a
decrease in quality of life as well as increased morbidity and mortality (9). Furthermore,
an estimated 70 to 100 billion dollars are spent annually on obesity related treatments (9,
20). Associations between body weight and health risk include increased incidence of
hyperlipidemia, diabetes mellitus, arteriosclerosis, infectious illness, heart disease, cancer
and hypertension (10, 11, 15, 20, 28, 31, 33-35). Most research has focused on obesity
and health risk, however, some research has indicated that very low weight individuals
have also been shown to have a relatively elevated mortality risk but the evidence is
mixed (4). Several investigators have implied that the etiology of the increased risk for
chronic disease with body weight may be related to an alteration of immune function (5,
8, 11, 14, 16, 28, 29,31,33,35).
Paragraph Number 2 Some investigators have attempted to better understand the
relationship of body weight and immune function. In a recent study that compared 116
obese (obesity was defined as a BMI between 25 and 65) and 41 non-obese (BMI less
than 25) women, obesity was linked to a decrease in immune function (28). In their study
and an additional study by Neiman et. al., measures of obesity were related to increased
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total leukocyte count (28, 29). An increase in total leukocyte count has been reported to
have a strong association with total cancer deaths and all cause mortality (12).
Furthermore, increased leukocytes have been reported as an independent risk factor for
cardiovascular disease (11, 28, 35).
Paragraph Number 3 The specific level of fatness at which one’s health becomes
impaired has not been determined; however research demonstrates that obesity adversely
affects health and longevity (23). Lohman (23) defines obesity as an excess of body fat
which may result in health impairments. In a majority of the research studies concerning 
obesity and health risk, BMI has been used as the indicator of excess body fat. 
Throughout the literature, a BMI of 30 kg/m or greater is associated with increased
health risk, with a majority of the research suggesting there may be a significant increase
•y
in health risk at a BMI of 25 kg/m (20). Because BMI is a mathematical representation
of height and weight and does not take into consideration body composition measures
such as body fat percentage or lean body mass (26), it may not be the ideal marker to
determine health risk related to obesity. In fact, BMI can be misleading in individuals
who have a high percentage of lean body mass or are short in stature (38). Baik et al. (6)
concluded that excessive body fat contributes to mortality at all ages. Therefore it may be
necessary to examine indices of body composition, such as fat mass versus lean body
mass, independently or in addition to BMI, to more accurately determine health risk.
Additionally, other researchers have looked at waist circumference and determined its
usefulness as an indicator of increased risk for cardiovascular disease and overall
mortality (17). It may be possible that percent fat and increased waist girth are related to
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an attenuation of baseline immune function, which in turn may increase risk for
morbidity and mortality. Therefore, the aim of this study was to investigate the
relationships among several anthropometric measures (weight, body mass index, body fat




Paragraph Number 4 Ninety-one male subjects were recruited from the Southern
California communities of Loma Linda University (LLU) and California State University
at Fullerton (CSUF). All subjects were between the ages of 19 and 45, inclusive; non-
smokers (must have quit at least six months prior to the participating in the study); did
not have a diagnosed chronic illness including (but not limited to): cardiovascular
disease, diabetes, autoimmune diseases, respiratory disorders, cancer; did not have an
infection, such as a cold, flu or other type of infection within the last month; were not
experiencing chronic pain; did not have serious sleep disturbances; did not have serious
allergies and did not have an allergic reaction with in the last month prior to participation
in the study; did not have salient emotional or mood problems; did not have a recent bone
fracture (with in the last six months); had not undergone surgery with in the last three
months; were willing to comply with study procedures; and were able to complete the
protocol as designed.
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Paragraph Number 5 The Institutional Review Boards (IRB) at LLU and CSUF
approved the experimental procedures, prior to initiation of the study. Informed consent
was obtained from all subjects.
Body Circumference and Composition Measures
Paragraph Number 6 Body Circumference Measurements. The methodology for
obtaining the waist and hip measurement were as described in the ACSM guidelines (1,
2). Subjects had their waist and hip circumference measured to the nearest quarter inch.
The measurements were taken with the subject standing in an erect position and their
abdomen relaxed. For the waist measurement, a horizontal measure was obtained at the
narrowest part between the xiphoid process and umbilicus. The hip measurement were
taken at the widest point above the level of the gluteal folds. Each measurement was
confirmed twice to the nearest quarter inch. The waist-to-hip ratio was then calculated
from the average waist and hip measurements.
Paragraph Number 7 Body Composition Measurements. Body composition was
assessed using the 7-site skin fold method. The seven subcutaneous skin fold sites
measured in this study were performed as described by the ACSM Guidelines (1,2). The
anatomical locations measured were: abdominal, chest/pectoral, midaxillary, subscapular,
suprailium, thigh and triceps. All skin fold measurements were performed twice for
accuracy and the average of the two measures was than calculated. Measures that were
not with-in two millimeters of each other were repeated. All skin fold measurements were
performed using a Lange Skin Fold Caliper (Cambridge Scientific Industries, Inc,
Cambridge, MD). Body density was determined by applying the 7-site regression formula
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as described in the ACSM guidelines (2). Percent body fat was then determined by the
Siri formula (23).
Paragraph Number 8 BMI Category and Percentage Fat Grouping. The subjects
were categorized into groups based on percentage body fat and BMI. The grouping for
percentage body fat were lean, normal and over fat as follows: Lean was defined as
having a percent body fat less than or equal to 10; Normal was defined as a body fat
percentage greater than 10 and less than 20; and over fat was defined as a percent body
fat equal to or greater than 20 (23). The grouping for BMI were underweight, normal and
overweight as follows: Underweight was defined as a BMI less than 19, normal was
defined as a BMI from 19 to less than 25 and overweight was defined as a BMI greater
than 25 (20).
Blood Analysis
Paragraph Number 9 All subjects reported to the laboratory between the hours of six and
nine in the morning in a 12-hour fasted state. All blood samples were taken from a vein
in the anticubital fossa with the subject in a seated position. Each subject had
approximately 25 milliliters (ml) of blood drwn into three separate vacutainer tubes.
Paragraph Number 10 Routine Complete Blood Counts (CBC). Routine CBCs were
performed by the Jerry L. Pettis Memorial Veterans Affairs Medical Center, Department
of Hematology, Pathological and Laboratory Medicine Services on an ADVIA 120
(Bayer Corporation, Bayer Diagnostics Division, Tarrytown, New York, USA).
Variables measured included, red blood cell count (RBC), hemoglobin (HGB),
hematocrit (HCT), platelet numbers (PLT), mean plasma volume (MPV), white blood
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cell count (WBC) and white blood cell differential (neutrophils, lymphocytes, monocytes,
eosinophils and basophils).
Paragraph Number 11 Mitogen Induced Lymphocyte Proliferation Assay. Mitogen
induced proliferation was determined using lymphocytes isolated from whole blood, and
stimulated with concanavalin A (Con A) and phytohemagglutinin (PHA) (37) .The
lymphocytes were isolated using lymphocyte separation medium (BioE, Fort Collins,
CO), washed and re-suspended in RPMI 1640 (Cellgro by Mediatech, Inc, Fisher
Scientific, Tustin, CA, USA) supplemented with L-glutamine and 10% heat inactivated
FCS (Summit Biotechnology, Fort Collins, CO, USA). The cells were counted on a 
hemacytometer using trypan blue exclusion to count only viable cells. The cells were 
resuspended at a concentration of 2.5 x 106 cells/ml. For each subject, 2.5x105 cells were
distributed to twelve-wells (one row) of a 96-well round bottom sterile microtiter plate.
Con A and PHA were added in quadruplicate to the lymphocytes at 1.5 pg/ml and 5
pg/ml respectively. Four wells received no treatment to serve as the unstimulated control
level of proliferation. The plates were incubated for 72 hours in a 37°C, 5% CO2
humidified incubator. After the 72 hour incubation, 20 jal of tetrazolium salt (MTT) at a
concentration of 5mg/ml was added to all wells and the plates incubated for an additional
4 hours (18). The plates were then centrifuged and the cell pellets washed with Phosphate
Buffered saline containing 1% calf serum. After washing, 150pls of acidified
isopropanol was added to all wells and the colored formazan product resuspended by
mixing (18).
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Paragraph Number 12 The plates were read at a 570nm wavelength on a microplate
spectrophotometer (Dynatech Laboratories Microplate Reader MRX, Thermo
Labsystems, Chantilly, VA, USA). The mean and standard error were determined for the
optical density measurements from quadruplicate samples. The percentage of mitogen
induced proliferation was calculated as the mean increase over the unstimulated levels.
The resulting experimental sample values were normalized using the control sample
values from an internal standard included in every experiment.
Statistics
Paragraph Number 13 Data were analyzed using SPSS 10.0 software package (SPSS,
Inc., Chicago, IL). Analysis included standard descriptive statistics and frequencies to
describe the sample demographics and parameters. Pearson correlation coefficients and
multiple regression procedures were used to test the linear relationship between
anthropometric measures and immune function. One-way ANOVA was used to compare
the three categories based on percent fat for all measured variables. Independent t-test
was used to compare the normal and overweight categories of BMI and to compare the
normal and overfat category of percent fat for all measured variables. Statistical
significance was set at the p< 0.05 and values are expressed in mean ± SE unless
otherwise noted.
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RESULTS
Demographics and Race
Paragraph Number 14 The data for three subjects were not included in the analyses due
to violation of the inclusion criteria (one had a serious allergic reaction less than six
months prior to the study and two were on antibiotics for recent infections). The data for
88 subjects were used for the analysis.
Paragraph Number 15 A majority of the subjects reported their race as Caucasian (49%)
while the other subjects reported Asian Pacific Islander (22%), Hispanic (18%) ,
American Black, (1%), Black, non-American (2%), and other (8%). For the
classification based on BMI, the percentage of subjects in each category were:
underweight, (4.5%); normal, (45.5%); and overweight, (50%). For the classification
based on body fat the percentage of subjects in each category were; lean, 9%, normal,
40%, and overfat, 51%. Twenty four percent of the subjects (n=21) were classified into
different groups dependent on BMI or percentage body fat: 11 of the subjects with a
'y #
normal BMI (mean = 23.7 kg/m ) were classified as over fat (mean = 24.7%); and ten 
subjects classified as overweight by BMI (mean = 26.8 kg/m ) and were classified as
normal according to percentage body fat (mean = 16.4%).
Anthropometric and Immune Measures
Paragraph Number 16 The anthropometric and immune measures for all subjects, BMI
and percent fat categories are shown in Table 1. The underweight group in the BMI
category was not included in the statistical comparison as the number of subjects was
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small (n=4). There were no significant differences for age and height across BMI or the
percent fat categories.
Paragraph Number 17 BMI Classification. Significant differences between the normal
and overweight groups were found for weight, waist measurement, hip measurement,
waist to hip ratio, percentage body fat, fat mass (FM) and fat free mass (FFM), all of
which were higher for the overweight groups (Table 1, p<0.05). However, no differences
were found between the normal and overweight groups as classified by BMI for any of
the immune and blood parameters.
Paragraph Number 18 Percentage Body Fat Classification. Significant differences
were found among all three categories of the percent fat classification for weight, BMI,
waist measurement, hip measurement, waist to hip ratio, percentage body fat, FM, WBC
and neutrophils, which were lowest in the lean group and highest in the over fat group
(Table 1). A significant difference was also found between the normal and over fat group
for platelet count (Table 1) with the over fat group having significantly higher platelet
counts. No significant differences were found across the three groups for FFM, or any of
the other immune or blood parameters.
Univariate Correlations
Paragraph Number IP For all subjects combined, BMI was significantly positively
correlated with the waist and hip measurements, waist-to-hip ratio, percentage body fat,
FM, FFM and WBC (Table 2, p<0.05). Percentage body fat was significantly positively
correlated with weight, BMI, waist, hip, waist-to-hip ratio, FM, WBC, PLT and
neutrophil count. WBC was significantly positively correlated with weight, BMI, waist,
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hip, waist-to-hip ratio, and FM. Percentage body fat and WBC were not correlated to
FFM (Table 2, p<0.05). In addition, lymphocyte proliferation, as determined by PHA and
Con A, was significantly correlated with mean plasma volume (r=0.23 and 0.25,
respectively, p<0.05). Lymphocyte proliferation was not correlated with any other
measured parameter.
Multiple Regression Model with WBC as the Dependent Variable
Paragraph Number 20 Multiple regression analysis was conducted to determine which
anthropometric variables independently predicted WBC. The model included weight, 
height, waist measurement, hip measurement, waist to hip ratio, LBM, FM, BMI and 
percentage body fat. Only FM was independently related to white blood cell count (R =
0.19, P=0.440 p<0.001). The regression equation for predicting WBC (103/pL) was: 
WBC (103/pL) = 0.025 * FM(kg) + 4.968.
DISCUSSION
Paragraph Number 21 Several long-term prospective studies have reported significant
positive associations between white blood cell (WBC) count and mortality (12, 13, 32).
Additionally, high WBC counts have been considered an independent risk factor for
coronary heart disease and have been associated with changes in coagulation factors,
glucose metabolism and triglyceride metabolism (19, 27, 30). Research shows that
obesity is related to higher WBC counts (29, 30). Specifically, increased BMI and
percentage body fat were related to increased white blood cell counts (r=0.44 and r=0.39,
respectively) with BMI having a stronger relationship (29). In the present study, WBC
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counts were also positively correlated with BMI and percent body fat (Table 2) as well as
waist circumference (p<0.05). However, percent body fat (r=0.35) and waist
circumference (r=0.30) were more strongly correlated to WBC count than BMI (r=0.25).
Furthermore, regression analysis indicated that FM alone was a significant predictor of
WBC. This suggests that the measurement of FM is more important than measures that
only rely on body weight when assessing morbidity and mortality risk.
Paragraph Number 22 The relationship between high body weight and
morbidity/mortality has been demonstrated throughout the literature (6, 7, 14, 15, 21, 38).
Most studies examining body weight and mortality done to date are large-scale
epidemiological studies which rely on BMI (10, 15, 27, 31) as the measure of obesity or
to estimate body composition (3). Several investigators have suggested that body fat
distribution may be a more accurate predictor of morbidity and mortality with truncal or
centrally located fat being associated with increased health risk for a variety of health
outcomes such as diabetes, hypertension, hypercholesterolemia and coronary heart
disease (3, 34). The present study supports this contention as indicated by the
significantly higher correlation of percentage body fat, FM and waist circumference to
WBC compared to BMI. Additionally, a number of our subjects (12.5%) that were
categorized as normal by BMI, had a high percentage body fat indicating that they would
be at a higher risk for disease. Thus, suggesting that BMI misclassifies overfat
individuals as normal with a low health risk.
Paragraph Number 23 In our study, the use of percentage body fat to determine if the
subject was lean, normal or overweight was a more sensitive measure than BMI when
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estimating morbidity and mortality risk based on total circulating WBC counts and
differentials. Although BMI was positively correlated with WBC (r=0.25, p<0.05), the
BMI categorization showed no significant difference between the normal and overweight
groups for WBC, neutrophil or platelet counts (Table 1). However, percentage body fat
was significantly correlated with WBC (r=0.35, p<0.005), neutrophils (r=0.35, p<0.005)
and platelets (r=0.21, p<0.05) and there were significant differences between the normal
and overweight groups for these markers (Table 1). Additionally, fat mass, percentage
body fat and waist circumference were more strongly related to WBC count than BMI
(Table 2). These results support epidemiological investigations suggesting that measures
relying on weight alone may not be sufficiently reliable enough predictors of mortality.
Future investigations concerning obesity and morbidity and mortality should include
measurements of body composition (4) and/or fat distribution. Furthermore, it is
suggested that joining two or more anthropometric measures to when assessing risk will
provide more accurate descriptions with more control of confounding variables (28).
Paragraph Number 24 Although this and other studies of the relationship of WBC count
and obesity provide some insight into a possible mechanism of action for increased
morbidity and mortality associated with obesity, the clinical significance remains unclear.
The clinical effect of increased leukocyte numbers depends greatly on the etiology. For
example, the clinical and biological significance associated with the change in leukocyte
numbers linked with chronic exercise are presently unknown (25). Danesh, et al (12)
suggest that the activity of the WBCs or platelets may be independently associated with
coronary heart disease, irrespective of the circulating types or numbers. This suggests that
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measuring the total WBC or platelet counts may not be a sensitive enough marker to
indicate a risk for mortality and morbidity. Additional markers for assessing immune
function and morbidity and mortality are suggested. For example, quantifying markers of
WBC activation, adhesion molecules or inflammation such as intercellular adhesion
molecule-1, may be more predictive of coronary events (22).
Paragraph Number 25 In summary, although BMI will continue to be a practical method
to estimate obesity, future investigations should include body composition and/or
measures of body fat distribution when assessing health risk related to obesity.
Additionally, the use of WBC count alone as a risk factor for morbidity and mortality
may not be clinically significant. The use of markers of WBC activation such as
cytokines or intercellular adhesion molecules, may be more sensitive markers.
Additionally, future investigations should attempt to include individuals from the more
extreme ends of the body composition continuum, for example, very lean or morbidly
obese. Inclusion of these populations may provide a more distinct picture of the
alterations in immune function based on percentage body fat. The results of this study
suggest that future investigations should utilize measures of body composition.
particularly fat mass, when investigating obesity-related health risks. Additional
epidemiological and experimental studies are needed to further support this conclusion.
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TABLE 1. Anthropometric and Selected Immune Characteristics of All Subjects, and
Categories of Subjects Based on BMI and Percentage Fat.
All subjects BMI Percent fat
Parameters
(N=88) UW (n=4) NL (n=40) OW (n=44) LN (n=8) NL (n=35) OF (n=45)
28.8 ± 0.7 25.5 ±1.0 28.8 ±1.0 . 29.2 ±1.0 26.25 ±1.4 28.3 ±1.0 29.7 ±1.0Age (yr)
178.9 ±3.3 176.7 ±1.3176.7 ±0.83 176.5 ±1.1 176.9 ±3.0 176.9 ±1.0 176.5 ±1.3Height (cm)
79.4 ±1.5 57.3 ±1.0 71.6 ± 1.1 88.6 ± 2.0a 63.5 ±2.4 74.4 ±1.5 86.2 ± 2.2bcWeight (kg)
25.5 ± 0.48 17.9 ±0.43 22.9 ±1.4 28.5 ± 0.63a 20.3 ±0.7 23.4 ± 0.44 27.7 ± 0.69bcBMI
81.9 ± 1.1 66.1 ±0.90 76.4 ±0.80 88.4 ± 1.3a 69.7 ±1.3 76.7 ±0.91 88.1 ±1.3bcWaist
99.5 ± 0.91 87 ±0.7 95.1 ±0.9 104.7 ±1.2a 90.0 ±0.88 95.6 ±1.0 104.3 ±1.2bbHip
0.82 ±0.005 0.76 ±0.02 0.80 ±0.008 0.84±0.008a 0.77 ± 0.009 0.81 ± 0.01 0.84 + 0.007 b'cWH ratio
19.8 ±0.78 10.5 ±3.1 16.2 ±1.0 23.8 ± 0.9a 6.2 ±0.73 15.33 ±0.50 25.6 ± 0.60bb% fat
16.34 ±0.9 6.04 ±1.8 11.74 ±0.8 21.47 ±1.2“ 3.89 ±0.48 11.44 ±0.44 22.37 ± 1.07^FM (kg)
63.08 ±0.86 51.23 ±1.7 59.82 ±1.0 67.11 ±1.1“ 59.60 ±2.4 62.96 ±1.2 63.79 ±1.3FFM(kg)
MIT PHA 
(n=85)
1.1 ±0.04 0.82 ±0.15 1.26 ±0.21 1.33±0.12 1.1 ±0.15 1.4 ±0.25 1.2±0.11
MTT Con A 
(n=85) 1.6 ±0.25 3.36 ±2.1 1.79 ±0.51 1.1 ±0.041.19 ±0.05 1.2 ±0.15 2.1 ±0.61
WBC 6.0 ±0.13 5.9 ±0.48 5.8 ±0.20 6.1 ±0.17 5.3 ±0.30 5.7 ±0.20 6.3 ±0.13 b’c(x103cells/fiL)
PIT 266.3 ±7.2 240.35 ±8.7 250.61 ±7.6 250.3 ±19.5 232.3 ±7.0 257.2 ±8.5“246.7 ±5.5(x103cells/pL)
3.3 ±0.22 3.1 ±0.163.2 ±0.09 3.2±0.13 2.8 ±0.27 3.0 ±0.17 3.4±0.13b-cNeutrophil
(x103cells/|j.L)
3 Independent t-test comparing the normal to overweight groups of BMI, p<0.05 
b ANOVA between all three groups for percent fat, p<0.05
c Independent t-test comparing the normal to over fat groups of percent fat, p<0.05 
Results are mean ± SE; UW, underweight; NL, normal; OW, overweight; LN, lean; OF, 
over fat.
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TABLE 2. Pearson Correlations Among BMI, Percentage Body Fat, WBC and Selected
Measured Parameters.
% Fat WBCBMIParameter
Age (yr) -0.180.01 0.13
Height (cm) -0.08 -0.03-0.21




0.21 b0.45c 0.52°WH ratio
0.35c0.70°% fat
0.85° 0.92c 0.36cFM (kg)
0.62cFFM (kg) 0.16 0.02
0.050.05 -0.05MTTPHA
-0.10 -0.06 0.08MTT Con A
0.35 b0.25 bWBC
0.21 b 0.28 bPLT* 0.12
0.35cNeutrophil3 0.18
(xl03cells/pL); b p < 0.05; cp<0.005
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ABSTRACT
Objective: To investigate relationships among several anthropometric measures (body
weight, body mass index, body fat distribution and body fat percentage) and selected
metabolic and endocrine parameters. Additionally to assess the relationship/association of
physical activity, as recommended by the United States Surgeon General, to/with selected
anthropometric and metabolic measures.
Design: Cross-sectional study of healthy males
Subjects: Ninety-one healthy males aged 19-45y (body mass index range 16.49 to 47.31 
kg/m2 ).
Measurements: Body mass index (BMI) was determined using the Quetelet formula 
(kg/m2), waist and hip circumferences were measured and percentage body fat was
assessed using the 7-site skin fold method. Planned physical activity was determined by a
self-report questionnaire. The metabolic and endocrine parameters included fasting blood
glucose (FBG), cortisol, triglycerides, and cholesterol panel including total serum
cholesterol (TC), low density lipoprotein (LDL), high density lipoprotein (HDL), very
low density lipoprotein (VLDL) and the TC/HDL ratio.
Results: Percentage body fat, fat mass, waist measurement and waist to hip ratio were
correlated to the TC/HDL ratio (p<0.0008). Percentage body fat was significantly
correlated with VLDL (P<0.008). Also, those subjects who reported participating in
physical activity as recommended by the US Surgeon General had lower VLDL
cholesterol and body fat levels than their more sedentary counter parts (p<0.05).
Conclusion: Body fat, fat mass and waist to hip ratio were more strongly related to
53
Anthropometric and Metabolic Measures
measures of lipid metabolism than BML In addition the results of this study suggest that
participation in planned physical activity at or above the level recommended by the US
Surgeon General would aid in reducing cardiovascular risk as indicated by a more
favorable blood lipid profile, decreased percentage body fat and overall fat mass. Key
words: BODY COMPOSIITON, FAT DISTRIBUTION, CHOLESTEROL, PHYSICAL
ACTIVITY.
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Introduction
Cardiovascular disease (CVD) continues to be the leading cause of morbidity and 
mortality in the United States1. Some important risk factors for CVD include
hypertension, obesity, cigarette smoking, diabetes, plasma glucose levels, plasma insulin
levels, triglycerides (TG) levels, and cholesterol, including total serum cholesterol (TC),
high density lipoprotein cholesterol (HDL), low density lipoprotein cholesterol (LDL),
very low density lipoprotein cholesterol (VLDL) as well as the ratio of TC to HDL 
(TC/HDL) 2’3. Risk factors are often interrelated such that a change in one is associated
with a change in another. For example, many studies have investigated the relationship of
physical activity and several CVD risk factors such as cholesterol and obesity and found
that physical activity has a positive effect on both factors independently and
2, 4,5synergistically
Participation in regular physical activity, specifically endurance training at a
sufficient intensity, is associated with a decrease in overall TG, VLDL and an increase in 
HDL cholesterol, indicating a favorable change in the lipid profile2,5'8. It has also been
documented that participation in physical activity is associated with decreased obesity, 
specifically decreased fat mass , suggesting a favorable impact on body composition .
Thus, increasing physical activity will favorably alter the CVD risk factor profile in at 
least two areas, if not more. In fact, Despres and Lamarche5 suggest that physical activity
resulting in a lowered body fat may lead to an improvement in several other risk factors
such as reducing abdominal adiposity, increasing insulin function as well as improving
the lipid profile.
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In order to better understand the association and integration of CVD risk factors it
is necessary to examine multiple risk factors simultaneously and evaluate possible 
interactions. Depres and Lamarche 5 discuss the concept of metabolic fitness related to
CVD risk. They define metabolic fitness as the metabolic variables that are included as
risk for cardiovascular disease which can be altered (positively) with physical activity. In
addition to examining metabolic fitness it is essential to evaluate the relationship between 
physical inactivity and chronic disease risk factors5. More information is needed to
understand the relationship of physical inactivity and health.
More than 60% of American adults do not participate in regular physical activity4.
The benefits of physical activity as related to reducing health risk factors have been well
4, 10, 11 . However, the underlying causality of morbidity and mortality related 
physical inactivity requires further investigation 4’12. Chakravarthy et al4 demonstrated
documented
this point: they clearly listed the benefits of physical activity for each described clinical
manifestation of physical inactivity. In addition, they have listed the cellular/molecular
mechanisms that underlie the benefits of physical activity for which many of the
categories have an unknown mechanism. The biological/cellular mechanisms by which
physical inactivity increases the chronic disease risk and through which physical activity
reduces these risks are poorly understood 4’5. Research is necessary to determine
relationships that integrate risk factors to provide a theoretical framework on which
to
further research can build. For example, Grundy proposes that the negative effects of
physical inactivity and obesity on insulin resistance may, in turn, be related to an increase
in the causal factors related to the incidence of CVD. Thus, the purpose of this study
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was 1) to examine the relationship among various anthropometric and metabolic
measures in a healthy, non-endurance trained males and 2) to investigate the possible
relationship of participation in physical activity, as suggested by the US Surgeon General,
and selected anthropometric and metabolic measures.
Subjects and Methods
Ninety-one male subjects were recruited from the surrounding Southern
California communities of Loma Linda University (LLU) and California State University
at Fullerton (CSUF). All subjects were between the ages of 19 and 45, inclusive; non-
smokers (must have quit at least six months prior to the participating in the study); did
not have a diagnosed chronic illness including (but not limited to): cardiovascular
disease, diabetes, autoimmune diseases, respiratory disorders, cancer; did not had an
infection, such as a cold, flu or other type of infection within the last month; were not
experiencing chronic pain; did not have serious sleep disturbances; did not have serious
allergies and have not had an allergic reaction with in the last month; did not have salient
emotional or mood problems; did not have a recent bone fracture (with in the last six
months); had not undergone surgery with-in the last three months; were willing to
comply with study procedures; and were able to complete the protocol as designed.
The Institutional Review Boards (IRB) at LLU and CSUF approved the
experimental procedures, prior to initiation of the study. Informed consent was obtained
from all subjects.
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Body Circumference Measures
Waist and hip measurement were taken to the nearest quarter inch, as described in the 
ACSM guidelines14. The measurements were taken with the subject standing in an erect
position and their abdomen relaxed. For the waist measurement, a horizontal measure
was obtained at the narrowest circumference between the xiphoid process and umbilicus.
The hip measurement was taken at the widest circumference above the level of the gluteal
folds. Each measurement was confirmed twice to the nearest quarter inch. The waist-to-
hip ratio was then calculated from the average waist and hip measurements.
Body Composition
Body composition was assessed using the 7-site skin fold method as described in the
14,15 . The anatomical locations measured were: abdominal,ACSM Guidelines
chest/pectoral, midaxillary, subscapular, suprailium, thigh and triceps. All skin fold
measurements were performed twice for accuracy and the average of the two measures
was then calculated. Measures not with-in two millimeters of each other were repeated.
All skinfold measurements were performed using a Lange Skinfold Caliper (Cambridge
Scientific Industries, Inc, Cambridge, MD). Body density was determined by applying 
the 7-site regression formula as described in the ACSM manual15. Percentage body fat 
was then determined by the Siri formula16. Fat mass (FM) was calculated by multiplying 
the percentage body fat by the total body weight. Lean body mass (LBM) was calculated
by subtracting the FM from the total body weight.
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Physical Activity
To assess the level of physical activity, a self-report questionnaire was developed with
the intention of collecting levels of physical activity and comparing those levels to that
recommended by the US Surgeon General. The questionnaire was designed to assess
planned physical activity (exercise) and spontaneous physical activity. A total physical
activity score was determined by adding the scores from the planned physical activity
section and spontaneous physical activity section. The overall range for total physical
activity score was zero to 34.5, with zero indicating that the individual does not
participate in planned physical activity (i.e. an exercise program) and is not active in their
occupation or leisure time. The physical activity instrument used for this study was not
previously tested for reliability or validity.
Planned physical activity was determined by assessing the number of days per
week the subject exercised, how long each exercise session lasted, type of exercise
(weights, cardiovascular, or combination of both), and intensity. Intensity was assessed
using a Rating of Perceived Exertion (RPE) scale. A planned physical activity score was
assigned based on a scale from zero to 27. Using this methodology, an individual whom
reported participating in moderate physical activity, 30 minutes a day for most days of
the week (at least four) as recommended by the US Surgeon General would be assigned a 
minimum planned physical activity score of fifteen .
Spontaneous physical activity was determined by assessing the physical activity
required by the subjects occupation, how often the subject takes the stairs as compared to
the elevator or escalator; how often they walk or ride on short trips; and how physically
59
Anthropometric and Metabolic Measures
active they are during their leisure time. A spontaneous physical activity score was
assigned based on a scale from zero to 7.5, with zero indicating little to no spontaneous
activity in their leisure time and/or at work.
Blood Analysis
All subjects reported to the laboratory between the hours of six and nine in the morning
in a 12-hour fasted state. Blood samples for measuring fasting blood glucose (FBG) were
obtained by the finger stick method in which the second finger of the non-dominant hand
was used. The fasting blood glucose analysis was determined using the FastTake
Glucometer (LifeScan, Milpitas, CA). All other blood samples were taken from a vein in
the anticubital fossa with the subject in a seated position. For this study, each subject had
approximately 25 milliliters (ml) of blood taken and distributed into three vacutainers.
Blood was taken from one of the investigators (the same each time) on each testing day to
provide a sample to be used as a control.
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Triglycerides and Cholesterol
For each subject 10ml of blood were collected into a heparinized vacutainer which was
then centrifuged at 1,500-1,800 rpm (Fisher Scientific Centrific, model #225, Fisher
Scientific, Tustin, CA, USA). Two milliliters of plasma were removed and stored in one-
mi sterile epitubes at -70°C. After the last subject had been tested, the plasma samples
were delivered, frozen, to the USC Lipid Laboratories (Los Angeles, CA) for analysis of
the TC, HDL and TG on a Cobas Mira Lipid analyzer (Roche Diagnostic System). LDL 
and VLDL cholesterol were estimated by the Friedewald equation17 afterwhich, the TC to
HDL (TC/HDL) cholesterol ratio was determined.
Cortisol
For each subject, a 10 ml blood sample was collected in a serum separator tube. The tube
was then centrifuged at 3,000 rpm (Fisher Scientific Centrific, model #225, Fisher
Scientific, Tustin, CA, USA) for 10 minutes. The serum was removed and stored at -
70°C in sterile epitubes. Once all samples had been collected, the serum was shipped.
frozen, to Endocrine Technologies, Inc (Newark, Ca) for determination of cortisol levels
using an Elyza Plate Reader (Biotech Instruments, model ELX 800). All samples,
including controls were analyzed simultaneously, at the end of the study.
Statistics
Data were analyzed using SPSS 10.0 software package (SPSS, Inc., Chicago, IL).
Analysis included standard descriptive statistics and frequencies. Pearson correlation
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coefficients were used to test the relationship between selected anthropometric
parameters and all metabolic measures. Additionally the correlations had the Bonferroni
adjustment applied to minimize the possibility of a Type 1 error and statistical
significance was determined by p < 0.0008. A z-score was calculated to investigate the
differences between the correlations for BMI and percentage body fat. Independent t-test
was used to compare the means of the exercising and non-exercising groups for all
measured variables. An LSD post-hoc analysis was done to further delineate the pairwise
relationships. Statistical significance was set at the p< 0.05 and values are expressed in
mean ± SE unless otherwise noted.
Results
Subject Characteristics
A majority of the subjects reported their race as Caucasian (49%) while other subjects
reported Asian Pacific Islander (22%), Hispanic (18%), American Black (1%), Black,
non-American (2%), and other, (8%). Table 1 lists the sample size, means and standard
error for age and anthropometric measures. The subjects ranged from underweight to
'y
obese as indicated by the BMI range of 16.5 to 47.3 kg/m and body fat percentage from 
very lean (4.0 %) to obese (35.6%). The waist to hip ratios ranged from 0.71 to 1.02.
Metabolic Parameters
Table 2 lists the number of subjects, range, mean and standard error for all measured
metabolic parameters. In comparison to standard reference ranges, 29% of the subjects
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had elevated levels of TC (>200 mg/dl), 52.7 % had high LDL (>100 mg/dl), 14.3% had
low HDL (<40 mg/dl), and 14% had high triglycerides (>200 mg/dl)18. The fasting blood
glucose values ranged from 74 to 259 mg/dl (mean = 89.2, SE = 2.0). The result for the
subject with the highest fasting blood glucose value (259 mg/dl) was confirmed with a
second finger stick test and he was referred to his primary care physician for follow-up.
No other subjects had clinically high FBG values (FBG > 1 lOmg/dl) and the FBG data
for this subject were excluded from the analysis.
Bivariate Correlations Among Anthropometric and Metabolic Measures
The results of the correlational analysis utilizing the Bonferroni adjustment to control for
a Type 1 error are presented in Table 3. Five out of the 56 (9%) anthropometric to
metabolic measure correlations were statistically significant (p<0.0008) and the
significant (r) values (absolute) ranged from 0.409 to 0.469. Four of the significant
correlations were positively related to the TC/HDL ratio: Waist (r= 0.428), W/H ratio (r=
0.409), % body fat (r= .469) and fat mass (r= 0.413). Additionally, percentage body fat
was significantly positively related to serum VLDL (r=0.405). This indicates that as
percentage body fat increases, there is an associated increase in the TC/HDL ratio and
serum VLDL levels. BMI did not show this association. There was a significant
difference between the correlational values (r) for BMI and percentage body fat as related
to TC, VLDL, LDL and TC/HDL. Such that Percentage body fat was more strongly
related to these parameters (p < 0.05), as indicated by the z-scores in Table 3.
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Physical Activity
Total physical activity scores ranged from zero, no physical activity, to 29, participating
in physical activity on a regular basis (mean = 16.6, SE=0.7). Thirteen subjects (14%)
reported not participating in any planned physical activity. The reported ranges for the
planned physical activity score (mean = 13.6, SE=0.7) and the spontaneous activity score
(mean = 3.2, SE = 0.2) were zero to 24 (high level of planned physical activity) and zero
to 7.5 (high level of activity during occupation or leisure time), respectively. For those
reporting participating in planned physical activity (n=78, 86%), 23 (29.5%) indicated
that they lifted weights for exercise, 24 (30.8%) listed participating only in cardiovascular
exercise and 31 (39.7%) reported participating in both modes of exercise.
Total exercise and planned physical activity were significantly (p < 0.05)
negatively related to waist circumference (r = -0.211 & r = -0.208, respectively),
percentage body fat (r = -0.277 & r = -0.238, respectively) and fat mass (r = -0.256 and r
= -0.231, respectively). Spontaneous physical activity was significantly negatively
related to fat mass (r = - 0.229, p < 0.05). Weight, BMI, hip circumference, waist to hip
ratio and lean body mass were not linearly related to any measure of physical activity.
Table 4 shows the means and standard errors for all measured parameters with the
subjects divided into two categories based on their planned physical activity score. The
increased physical activity group (n= 47) reported participating in physical activity at a
level that is recommended by the US Surgeon Generals report (a score of 15 or greater on 
the planned physical activity scale) . The less physically active group (n=44) did not
meet this recommendation (receiving a score of less than 15 on the planned physical
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activity scale). The more physically active group had a significantly lower waist to hip
ratio, percentage body fat, fat mass and VLDL cholesterol than their more sedentary
counterparts (p < 0.05). The two groups did not differ statistically on any other
parameters.
Discussion
Obesity, particularly fat mass, has been associated with an unfavorable atherogenic
lipoprotein profile, which in turn is recognized as one of the major cardiovascular risk 
factors 19. In our study, all measures of obesity (weight, BMI, waist measurement, waist-
hip ratio, % fat and FM) were significantly negatively correlated with plasma HDL
cholesterol (p < 0.05), suggesting that as body fat and body weight increase plasma HDL
cholesterol decreases. However, these correlations were not significant after the
Bonferroni adjustment. The waist circumference measurement, which is used as a
measure of abdominal adiposity, had the highest inverse correlation with HDL (r=-0.324,
p< 0.002). Although these data were not statistically significant according to th stringent
criterion level demanded in this study, clinically they are important as low levels of HDL
cholesterol have been suggested to be a powerful predictor of heart disease, greater than a
90elevated total serum cholesterol. Additionally, central obesity has clearly been
associated with several CVD risk factors including lipid profile, hyperinsulinemia and 
insulin resistance21 and metabolic changes related to obesity22.
TC/HDL ratio has been associated with overall obesity as well as abdominal 
obesity. Kinosian, Click and Garland suggest that use of the TC/HDL ratio is better
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measure of CVD risk than plasma LDL-cholesterol or TC alone. Other researchers
indicate that a combination of TC/HDL along with the plasma cholesterol levels are the 
best indicators of risk. Hodis and Mack24 examined the atherosclerosis progression using 
coronary angiographic and carotid arterial wall intima-media thickness measurements.
They concluded that triglyceride rich lipoproteins, such as VLDL, are associated with the
progression of atherosclerotic lesions, which have been implicated for clinical coronary 
events24. In our subjects, several of the measures of obesity had a direct correlation with
the TC/HDL ratio (Table 3). Percentage body fat was correlated with all of the
cholesterol measures (p < 0.05) and was most strongly related to VLDL (r=0.405, p <
0.0001) and the TC/HDL ratio (r=0.409, p < 0.0001), suggesting that increased obesity as
assessed by percentage body fat is related to a decrease in the lipid profiles thus
increasing CVD risk. In this study, BMI was not significantly related to any of the 
metabolic measures. Thus, clinically, BMI may not be as good measure of obesity or 
cardiovascular risk in healthy males as percentage body fat.
The data regarding blood lipids and physical activity are well documented in 
athletes2,5’7’8. Many studies have examined the relationship between activity and lipids 
including TG, TC and lipoportien sub-fractions2,7. In a review of the literature, Durstine 
and Haskell2 report that participation in regular physical activity, in particular endurance
training at a sufficient level of intensity, is associated with a decrease in overall TG , 
VLDL and an increase in HDL cholesterol. For example, Hespel et al7 studied the
changes in plasma lipids in 27 healthy sedentary males after 48 training sessions
(bicycling jogging and dynamic calisthenics) over approximately 16 weeks. They
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0.05), TC (p < 0.01), LDL (p < 0.001), VLDL (p < 0.05) and an increase in HDL (p <
0.01).
In our subjects, those subjects who reported participating in regular physical
activity at or above the level as prescribed by the US Surgeon General (30 minutes a day
of moderate physical activity on most days of the week), had significantly lower levels of
VLDL (p < 0.05), percentage body fat (p < 0.05) and overall fat mass (p < 0.05) than
those who reported that they did not participate in regular physical activity at the
recommened level (Table 4). Additionally, the active individuals had lower TC and LDL
levels and higher HDL levels and TC/HDL ratios, although these results did not reach
significance. The overall better lipid profile in the more active subjects may be related 
to the decreased body fat. For example, Depres et al22 studied the effects of a 14 month.
low intensity (55% VOimax) endurance training program in a group of premenopausal
women (n=12). They reported significant decreases in weight, fat mass and LDL
cholesterol and increases in HDL cholesterol and several HDL cholesterol subtractions
post exercise (p < 0.05). Moreover, they found that the changes in metabolic parameters
were not correlated with fitness (as assessed by VO2 max) but were correlated with the
changes in abdominal adiposity (r=-0.66, p < 0.05). Thus, positive changes in metabolic
parameters associated with physical activity may be more strongly related to the 
proportionate changes in body fat rather than cardiovascular fitness .
The lack of significance found for some of the key variables in the present study
may be due to several factors. First, there was a lack of precision of the methods
employed to measure physical activity and the lack of use of an objective measure of
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fitness such as VOimax. Physical activity level was determined by self-report collected
on an instrument not evaluated for validity and reliability. This type of method is subject
to recall bias and respondent bias. Thus the physical activity data may not be valid.
Secondly, in a review of the literature, the results for LDL changes in response to
physical activity are inconsistent and do not differ between active individuals and their 
sedentary counterparts in many of the studies reviewed5. These authors suggest that 
plasma LDL cholesterol may not be a good indicator of the LDL subfractions such as 
small LDL, large LDL and intermediate density lipoproteins (IDL)5. The smaller, denser 
LDL particles are suggested to increase athrogenicity even if the LDL cholesterol is not 
elevated23. Future investigations should include the LDL subtractions when analyzing 
lipid profiles. Finally, although our active subjects had a significantly lower level of
VLDL cholesterol, their overall TG levels did not differ significantly (p=0.67). The lack
of significance in TG and HDL levels between the less and more active groups may be 
related to the level or intensity of exercise reported by our subjects as none of our 
subjects were endurance trained athletes. Durstine and Haskell indicate that the amount
of TG reduction in response to exercise is dependent on the baseline TG levels and in
most studies reviewed endurance training (for example, endurance athletes and cross 
country skiers) did result in lower TG levels. Additionally, changes in adiposity did not 
account for low TG levels in the active individuals studied . Research has suggests there
is a dose response relationship between the increase in HDL cholesterol related to 
physical activity and is dependent upon volume, intensity of exercise training, body 
composition and pre-training HDL cholesterol levels . Thus, participation in physical
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activity as suggested by the US Surgeon General may be a sufficient stimulus to improve
certain measures of cholesterol, such as VLDL, and to lower percentage body fat.
However, increases in the intensity, frequency and or duration of exercise may be
necessary to achieve a greater reduction in body fat and a more favorable overall lipid
profile.
In summary, selected measures of body weight and fat were correlated to selected
measures of cholesterol (VLDL and TC/HDL ratio). Also, those subjects who reported
participating in physical activity at the level recommended by the US Surgeon General
had lower VLDL cholesterol and body fat levels than their more sedentary counter parts.
These results suggest that participation in planned physical activity at or above the level
suggested by the US Surgeon General will aid in reducing cardiovascular risk as
indicated by a more favorable blood lipid profile and decreased percentage body fat and
overall fat mass. A well controlled randomized study needs to be done to investigate the
changes in metabolic fitness and the protective effects of exercising at the level
recommended by the US Surgeon General, targeting the complex interactions between
exercise, body fat loss and changes in lipid profiles.
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TABLE 1. Demographic and Anthropometric
Characteristics of All Subjects
N = 91 Mean ± SE
Age (yrs)* 28.71 ±0.66
Height (cm) 176.63 ±0.82
Weight (kg) 79.3 ± 14
BMI (kg/m2) 25.5 ± 4.4
Waist (cm) 81.8 ± 1.0
Hip (cm) 99.5 ± 0.9
W/H ratio 0.82 ± 0.006
% body fat 19.5 ± 1.2
LBM (kg) 63.2 ±0.9
FM (kg) 16.1 ±0.9
*N=90
Results are: W/H, Waist to Hip ratio; LBM,
Lean Body Mass (kg); and FM, Fat Mass (kg).
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TABLE 2. Metabolic Parameters for All Subjects
RangeParameter Mean ± SEn
TC (mg/dl) 86-283 183.86 ±4.0791
VLDL (mg/dl) 89 12-130 32.1 ± 1.8
LDL (mg/dl) 88 31.3 - 186.3 103.5 ±3.4
HDL (mg/dl) 90 31-81 49.6 ± 1.1
TC/HDL 90 2.18-6.75 3.9 ±0.11
TG (mg/dl) 91 48-657 138.9 ±10.0
Cortisol (ug/dl) 89 0.61-9.4 3.81 ±0.19
FBG (mg/dl) 89 74.0-259.0 87.3 ±0.74
Results are: TC, Total Serum Cholesterol; VLDL, Very Low Density Cholesterol; LDL,
Low Density Cholesterol; HDL, High Density Cholesterol; TG, Triglycerides; FBG,
Fasting Blood Glucose.
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Parameter Wt BMI Waist W/H % fat LBM FM
(mg/dl)
TC ( n = 9 0 ) 0.009 0.102 0.187 0.239* 0.343* -0.233* 0.238* z = -2.99*
0.405* # -0.182 0.299* z = -2.92*VLDL (n=89) 0.074 0.182 0.258* 0.285*
LDL (n = 89) 0.024 0.074 0.179 0.243* 0.259* -0.157 0.192 z = -2.32*
HDL (n = 90) -0.241* -0.248* -0.324* -0.258* -0.261* -0.132 -0.275* z = 0.13
TCS/HDL (n=90) 0.228 0.297* 0.428*'# 0.409*'# 0.469*’# 0.035 0.413*' # z - -2.26*
TG (n=90) 0.036 0.096 0.174 0.292* 0.185 -0.079 0.134 z =-1.10
Cortisol 
(ug/dl, n=91)
-0.048 -0..095 -0.021 0.132 -0.086 0.019 -0.099 z = -0.12
FBG ( n=90) .0.010 0.031 0.122 0.183 0.154 -0.094 0.106 z = -1.45
><0.05
# Bonferonni approach applied, p < 0.0001
Results: Pearson’s bivariate correlation coefficients; Wt, weight (kg), BMI, body mass
index, Waist (cm), W/H, waist to hip ratio, % fat, percentage body fat, LBM, lean body
mass (kg) and FM, fat mass (kg).
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TABLE 4. Comparison of Physical Activity as Recommended by the
U.S. Surgeon General, Anthropometric and Selected Metabolic Measures.





27.7 ± 0.90 29.8 ± 1.0 




0.83 ± 0.009* 
21.5 ± 1.2* 



































4.0 ± 0.26 3.7 ±0.29 
87.33 ± l.l"90.8 ±3.8
independent t-test for mean differences, p < 0.05
* N= 42
Results are mean ± SE; PA, Physical Activity; Increase PA indicates participation in 
exercise greater than 30 minutes per day of moderate intensity physical activity on most 





Until recently there has been a paucity of studies regarding the relationship of
cortisol, exercise and obesity. High cortisol has been- associated with many
cardiovascular risk factor including hypertension, insulin resistance, and changes in lipid
metabolism (Fraser, Ingram, Anderson, Morrison, Davies & Connel,1999). Recently,
cortisol levels have been associated with a characteristic fat distribution including an
increased abdominal adiposity such as that demonstrated in an endocrine disorder,
Cushing’s syndrome (Fraser, et al., 1999). Fraser, et al. (1999) suggests that even small
(but chronic) increases of cortisol may increase abdominal fat deposition which is a
strong indicator of cardiovascular disease risk. In the present study we compared cortisol
levels to body habitues and physical activity.
B. Serum Cortisol, Anthropometric Measures and Physical Activity
In our study, serum cortisol levels were measured to examine the possible
relationships among cortisol, measures of obesity (BMI, waist measurement, hip
measurement, W/H ratio, percentage body fat, fat mass and lean body mass) and reported
physical activity. Serum cortisol levels (mean = 3.8 pg/dl ±0.19) were not significantly
related to any of the anthropometric measures or reported participation in physical
activity or spontaneous activity.
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Additionally, we did not find a relationship between plasma cortisol and any of
the anthropometric measures. It has been suggested that urinary excretion of cortisol but
not plasma cortisol may be correlated with anthropometric parameters (Fraser, et al.,
1999). Furthermore, the level of obesity in the present study was mild (mean percentage
body fat = 19.51, SE ^ 1.2, n=91) and may not have been sufficient to differentiate serum
cortisol levels.
The results of this study did indicate an interesting association between cortisol
levels and type of physical activity (cardiovascular, weights or both). When examining
those who reported participating in planned physical activity (n=78), 30% (n=23)
reported participating in weight training (weight group), 31% (n=24) reported
cardiovascular exercise (CV group), and 39 % (n=31) reported participating in both
weights and cardiovascular (combined group). Fourteen percent (13) of the total
participants reported that they did not participate in any physical activity. As indicated in
Figure 3, subjects who were in the weights only group had a significantly (p < 0.05)
higher level of morning serum cortisol level than those in the CV group and those
reporting not participating in physical activity. There was no significant difference
between the weight group and the combined group, although the combined group had
higher serum cortisol levels than the CV group and those not participating in physical
activity.
Increased cortisol levels have been shown to impact the immune system and it has
been postulated that glucocorticoids (cortisol is classified as a glucocorticoid) are potent
immunosuppressive agents (DeRijk, Peterides, Deuster, Gold, & Sternberg, 1996). T-
lymphocytes are particularly acutely sensitive to the glucocorticoids as shown by a
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decrease in activity in the presence of high cortisol (Solomon, 1996). For example,
increased cortisol has an immunosuppressive effect on T-lymphocytes as indicated by
reduced lymphocyte proliferation and altered cytokine response (Falaschi, Martocchia,
Proietti & D'Urso, 1999). The clinical significance of physiological fluctuations of non­
stress, basal cortisol levels are unknown, however, there have been case reports that non­
stress basal levels of cortisol may negatively influence the immune system (DeRijk,
Michelson, Karp, Petrides, Galliven, Deuster, et al., 1997). Most of the studies examining
cortisol levels and resistance exercise training included heavy resistance training for the
experimental group and found no significant difference between pre and post training,
resting cortisol levels (Kraemer, Hakkinen, Newton, Nindl, Volek, McCormick, et al.,
1999; Flynn, Fahlman, Braun, Lambert, Bouillon, Brolinson, & Armstron, 1999; McCall,
Byrnes, Fleck, Dickinson, & Kraemer, 1999). The results of the present study need to be
confirmed in a well-controlled clinical trail. Further investigation is recommended to
examine the benefits of participation in an exercise program that combines resistance and
cardiovascular training to obtain optimal resting levels of serum cortisol.
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A. Summary and Implications of Findings
This study identified relationships between anthropometric measures and selected
markers of chronic disease including immune, metabolic and endocrine function.
Percentage body fat, fat mass and waist circumference, all of which are markers of
obesity, were independently more strongly related to white blood cell count than BMI.
These results support epidemiological investigations suggesting that measures relying on
weight alone may not be a reliable enough predictor of mortality and that future
investigations concerning obesity and morbidity and mortality should include
measurements of body composition and/or fat distribution (Allison, Faith, Heo & Kotler,
1997). Furthermore, although not investigated in the present study, it is suggested that
combining two or more anthropometric measures to model variables will provide more
accurate descriptions with more control of confounding variables (Michels, Greenland &
Rosner, 1998).
Additionally, selected measures of obesity (waist measurement, W/H ratio.
percentage body fat and fat mass) were correlated to measures of cholesterol (VLDL and
TC/HDL ratio). Body mass index did not show these associations. Also, those subjects
who reported participating in physical activity at or above the level recommended by the
US Surgeon General had lower VLDL cholesterol and body fat percentage levels than
their more sedentary counterparts. There were no differences among any of the other
metabolic factors for these two groups. These results suggest that participation in planned
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physical activity at or above the level suggested by the US Surgeon General will aid in
reducing cardiovascular risk as indicated by a more favorable blood lipid profile.
decreased percent body fat and overall fat mass. However, increased exercise load
(intensity, frequency or duration) may be necessary to positively impact a range of risk
factors for chronic health conditions.
B. Strengths and Limitations
One limitation to this study is the lack of precision of the methods employed to
measure physical activity. Physical activity level was determined by self-report which
was collected using an instrument that was not evaluated for validity and reliability.
Additionally, this type of method is subject to recall bias and respondent bias. Thus the
physical activity data may not be accurately represented. Secondly, many of the markers
used in our study may not be sensitive enough to determine alterations based on body
composition. For example, in a review of the literature, the results for LDL cholesterol in
response to physical activity are inconsistent and do not differ between active individuals
and their sedentary counterparts in many of the studies reviewed (Despres & Lamarche,
1994). These authors suggest that plasma LDL cholesterol may not be a good indicator of
the LDL subfractions such as small LDL, large LDL and Intermediate density
lipoproteins (Despres & Lamarche, 1994). The smaller, denser LDL particles are
suggested to increase athrogenicity even if the LDL cholesterol is not elevated (Henry,
2001). Furthermore, the subjects in this study were males, between the ages of 19 and 45
years thus limiting our ability to generalize across age and gender. Finally, although a
large range of body compositions were represented in the study, the number of subjects in
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the very high and low ends were limited thus minimizing the variability in immune,
metabolic and endocrine function where we expected to find an association with high
and low percentage body fat.
C. Recommendations
1. Preventive Care
From a preventive care perspective, these results support the
recommendations that medical professionals should counsel patients to increase their
participation in physical activity, increase lean body mass and decrease fat mass to reduce
the risk of chronic health conditions (Chakravarthy, Joyner & Booth, 2002). Thus,
prescription of physical activity, at or above the level recommended by the US Surgeon
General, should become an important mode of primary prevention to reduce chronic
disease risk factors and overall mortality risk. This combined with a well balanced diet
that promotes maintenance of a healthy body weight and body composition should be a
substantial goal in preventive care.
2. Future Research
One of the main goals of an exploratory study of this nature is to identify
areas or directions for future research. The results of this study certainly met that goal.
Future analysis should include a well controlled randomized study to investigate the
changes in metabolic fitness and the protective effects of exercising at the level
recommended by the US Surgeon General, targeting the complex interactions among
exercise, body fat loss and changes in lipid profiles. Investigations may be done that
employ the use of more reliable markers for immune and endocrine function, such as
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cytokines, markers of WBC activation, adhesion molecules or markers of inflammation,
urinary cortisol excretion or secretion of adrenocorticotropin hormone (Fraser, Ingram,
Anderson, Morrison, Davies & Connel, 1999; Libby & Ridker, 1999). Furthermore,
additional investigations are needed to determine the benefits of including cardiovascular
exercise in any physical activity program as opposed to participating in exclusively
weight training.
Additionally, much of the latest cholesterol research is moving away from using
straight lipid profiles to using more discrete markers of lipid metabolism such as
lipoprotein sub-fractions and quantification of apo-proteins. Further studies are needed to
confirm the relationships found in the present study using a more diverse population base.
For example, future investigations should investigate the effects or differences of race,
age, gender and a greater range of body habitues on the measured parameters.
Furthermore, future investigations should employ a reliable and valid method for
capturing participation in physical activity, which ultimately could be correlated with
markers of physical fitness such as maximum oxygen consumption.
D. Conclusion
In conclusion, this study demonstrated the necessity to further evaluate the
accuracy of using BMI to assess obesity or chronic health risk in an adult male
population. Percentage body fat appears to be a more reliable indicator. Additionally, the
results of this study are in agreement with the latest recommendations of the positive
health benefits of regular participation in physical activity. Further investigation is
necessary to determine the optimal level of physical activity, however, the US Surgeon
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General recommendations are certainly a good starting place for those who are presently
inactive. Based on the results of this study, medical professionals, preventive care
specialists and allied health professionals are encouraged to obtain measurements of body
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Body Composition and immune Function
Purpose and Procedure
You have been invited to participate in a research study because you 
are between the ages of 19 and 46, are male and do not participate in 
regular exercise.
The purpose of this study is to look at your immune system and 
compare it with your percent body fat and see if there is any 
relationship.
Participation in this study will require approximately 30 minutes of your 
time.
Participation in this study will require the following procedures to be 
performed:
i. Approximately 2 tablespoons of blood will be taken from the inside 
of your elbow. A certified lab technician will take the blood sample.
ii. Your finger will be stuck to obtain a drop of blood to measure your 
blood sugar levels.
iii. Your skin will be gently pinched at seven different parts of your 
body (in the back of your arm, upper chest, back, belly, hip, under 
arm and thigh) to determine your fat to muscle ratio.






Pain and minor bruising at the site of needle insertion and finger stick site and possible 
lightheadedness upon arising after the blood is drawn, are possible complications of the 
blood drawing. The committee at Loma Linda University that reviews human studies 
(Institutional Review Board) has determined that participating in this study exposes you to 
a minimal risk.
Benefits
The benefits to you include medical lab test results such as: cholesterol, triglycerides, 
fasting blood glucose, hematocrit, hemoglobin, selected immune parameters and 
knowledge of your body composition. You will be provided an opportunity to discuss the 
lab test results and will be referred to a physician if necessary. In addition, the information 
gathered by this study may be beneficial to both the advancement of science and society 
as a whole. Obesity, excessive fat and inactivity may lead to an increased risk of becoming 
ill or dying. With the results of this study we may be able to better understand why these 
conditions may lead to illness or death.
Your Rights
Participation in this study is voluntary. Your decision whether or not to participate or 
terminate at any time will not affect your present or future medical care.
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Informed Consent
Body Composition and Immune Function
Confidentiality
Any information provided to the investigator, including lab test results, will remain 
confidential.
Costs
There is no cost to you for participating in this study.
Research Related Injury
In the event of physical injury resulting form this research, appropriate emergency medical 
treatment will be provided. If you should sustain injury as a result of this research, no 
provision has been made for financial payments or other forms of compensation,
Impartial Third Party Contact
If you wish to contact an impartial third party not associated with this study regarding any 
question or complaint you may have about the study, you may contact the Office of Patient 
Relations, Loma Linda University Medical Center, Loma Linda, CA 92354, phone (909) 
558-4647 for information and assistance.
Informed Consent Statement
I have read the contents of the consent form and have listened to the verbal explanation 
given by the investigator. My questions concerning this study have been answered to my 
satisfaction. I hereby give voluntary consent to participate in this study. Signing this 
consent document does not waive my rights nor does it release the investigators, 
institution or sponsors from their responsibilities. I may call Dr. Bryan Haddock, DrPH, 
during routine office hours at (909) 558-4741 if I have additional questions or concerns.
I have been given a copy of this consent form.
Signatures
Signature of subject Date
Signature of Witness Date
/ have reviewed the contents of the consent form with the person signing above. I have explained 
potential risks and benefits of the study.
Signature of Investigator Phone number Date
Page 2 of 2
Body Composition and Immune FunctionInitials Date
102
Appendix B
Approval Letter, Loma Linda University
103
IOSR# SliulINSTITUTIONAL REVIEW BOARD
Initial Approval Notice - Expedited Review
OFFICE OF SPONSORED RESEARCH • 11188 Anderson Street • Lome Unde. CA 92350. 
(909) 558-4531 (voice) • (909) 558-0131 (fax)
To: Bryan L. Haddock, MS 
Health Promotion & Education





The protocol and consent form for this study were reviewed and approved administratively on behalf of 
the IRB. This decision includes the following determinations:
1. Risk to research subjects: Risk > Minimal
2. Approval period begins 06/14/2001 and ends 06/13/2002.
3. Conditions of approval are: <None Specified>
Consent Form
If a written consent form is required, approval will be indicated by the affixed IRB approval stamp. This 
now becomes your official consent form for the dates specified and should be used as a master for 
making the necessary copies.
Adverse Events / Protocol Changes
The IRB should be notified in writing of any modifications to the approved research protocol. All adverse 
effects, anticipated or not, should be reported to the IRB: serious events should be reported within seven 
days; ail others within 15 days.
Protocol Review
Your protocol is tentatively scheduled for review and renewal at the meeting of the IRB in 
To assure uninterrupted approval of this project, you will be sent a status report form to complete and 
return prior to this date. In addition to reporting the number of subjects enrolled, you may close the study 
or request renewal at this time.
Records
All records relating to this project, including signed consent forms, must be kept on file for three years 
following completion of the study.
Please note the Pi's name and the OSR number assigned your IRB application (as indicated 
above) on any future communications with the IRB about this project. Direct all communications 
to the IRB c/o the Office of Sponsored Research.
Thank you for your cooperation in LLU's shared responsibility for the ethical use of human subjects in 
research.
Signature of IRB Chair/Vice Chair"i*s4^?Q ^ Date:.
The Institutional Review Board holds Multiple Public Assurance (MPA) No. M-129S with the U.S. Office for Protection from Research Risks and is assigned ID#01NR. This 
Assurance applies to the following institutions: loma Linda University (and its affiliated medical practice groups). Loma Linda University Medical Center (including Loma 




Office of Sponsored Research 
Ext. 43570, FAX 80131, lhalstead@univ.llu.edu Ext 43042, FAX 80131, jrkraus2@univ.llu.edu
IRB Chair:




Linda G. Halstead, M.A., Assoc. Director 
Office of Sponsored Research
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Informed Consent
Body Composition and Immune Function
Purpose and Procedure
You have been invited to participate in a research study because you are between the ages of 19 
and 46, are male and do not participate in regular, intense exercise. The purpose of this study is to 
look at your immune system and compare it with your percent body fat and see if there is any 
relationship. Participation in this study will require approximately 30 minutes of your time.
Participation in this study will require the following procedures to be performed:
• Approximately 2 tablespoons of blood will be taken from a vein on the inside of your elbow. A 
trained lab technician will take the blood sample.
• Your finger will be stuck to obtain a drop of blood to measure your blood sugar levels.
• Your skin will be gently pinched at seven different parts of your body (in the back of your arm, 
upper chest back, belly, hip, under arm and thigh) to determine your fat to muscle ratio.
• Your waist and hips will be measured using a tape measure.
Risks
Pain and minor bruising at the site of needle insertion and finger stick site and possible 
lightheadedness upon arising after the blood is drawn, are possible complications of the blood 
drawing. Participating in this study exposes you to a minimal risk of injury due to the drawing of 
blood.
Benefits
The benefits to you include medical lab test results such as: cholesterol, triglycerides, fasting blood 
glucose, hematocrit, hemoglobin, selected immune parameters and knowledge of your body 
composition. You will be provided an opportunity to discuss the lab test results and will be referred 
to a physician if necessary. In addition, the information gathered by this study may be beneficial to 
both the advancement of science and society as a whole. Obesity, excessive fat and inactivity may 
lead to an increased risk of becoming ill or dying. With the results of this study we may be able to 
better understand why these conditions may lead to illness or death.
Your Rights
Participation in this study is voluntary. Your decision whether or not to participate or terminate at 
any time will not affect your present or future medical care.
Confidentiality
Any information provided to the investigator, including lab test results, will remain confidential.
Costs
There is no cost to you for participating in this study.
Page 1 of 2
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Informed Consent
Body Composition and Immune Function
Research Related Injury
In the event of physical injury resulting form this research, appropriate emergency medical 
treatment will be provided. If you should sustain injury as a result of this research, no provision 
has been made for financial payments or other forms of compensation,
Impartial Third Party Contact
If you wish to contact an impartial third party not assodated with this study regarding any question 
or complaint you may have about the study, you may contact the CSUF Institutional Review Board 
Coordinator at (714) 278-7640 for information and assistance.
Informed Consent Statement
I have read the contents of the consent form and have listened to the verbal explanation given by 
the investigator. My questions concerning this study have been answered to my satisfaction. I 
hereby give voluntary consent to partidpate in this study. Signing this consent document does not 
waive my rights nor does it release the investigators, institution or sponsors from their 
responsibilities.
I may call Janet Peterson, Dr.P.H. (candidate), during routine office hours at (949) 643-9150 if I 
have additional questions or concerns. I have been given a copy of this consent form.
Signatures
Signature of Subject Date
Signature of Witness Date
I have reviewed the contents of the consent form with the person signing above. I have explained potential 
risks and benefits of the study.
Signature of Investigator Date
Page 2 of 2
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Office of Grants & Contracts 
(714) 278-2106 / Fax (714) 278-3000
MEMORANDUM
DATE: July 13, 2001
TO: Janet T. Peterson
Kinesiology and Health Promotion P-134
Dr. William Beam, Chair
Institutional Review Board (IRB)
FROM:
RE: Application for Use of Human Subjects HSR-01-114
Your proposal entitled "The Influence of Body Composition on Immune Function" has been 
reviewed and approved by the IRB. Your use of human subjects may commence 
immediately.
You will find attached an approved copy of your proposal. Please adhere closely to the 
guidelines for human subject use as you have described them and inform the Board of any 
changes should they be needed. Your use of human subjects has been approved for the 
period of one year.
Please return the enclosed completion form once your work with human subjects is 
finished. If it becomes necessary to extend your use of human subjects beyond one year, 
you will need to submit the continuation portion of the form. Good luck with your 
research.
i/n/oi
Date of Approvaliignature of IRB Chair 
Indicating Approval
cc: Lori Jennex
Office of Grants and Contracts, MH-112
California Stati University, Fullerton P O. Box 6850, Fullerton, CA 92834-6850
The California State University; Bakersfield / Channel Islands / Chico / Dominguez Hills / Fresno / Fullerton / Hayward / Humboldt / Long Beach / Los Angeles / Maritime 





UNIVERSITY LIBRARY " 
LOMA LINDA, CALIFORNIA
Immune Function and Body Composition 
Health Status and Exercise Survey
Subject ID:Exercise Evaluation
investigator use only
1. How many days per week do you normally exercise: 0123456 7
2. What type of exercise do you do? (examples: weights, cardiovascular)
3. For what duration (in minutes) do you normally exercise at each session?
45 or more
4. Circle the number which best describes your physical effort during normal exerdse:
15-30 30-45Less than 15













5. How long have you been regularly participating at the physical activity level described in questions1&2?
Not regular Less than 1 year 1-2 years 2-3 years 3 or more years
6. How physically demanding is your occupation (amount of physical activity required by your work)
Moderately activeMildly active
7. How often do you use the stairwell instead of an elevator or escalator?
Almost never Occasionally
8. How often do you ride a bicycle or walk on short trips as opposed to using an automobile?
Almost never Occasionally










Frequently Most of the time












As Active More Active
11. Considering a 7 day period (1 week), during your leisure time how often do you engage in regular 
activity long enough to work up a sweat (heart beats rapidly)?
SometimesRarely OftenNever
Thank youlll Please return this form to the investigator— ©
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